Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans-Jürgen Möller

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schennach-Wolff Rebecca; Jäger Markus; Seemüller Florian; Obermeier Michael; Messer Thomas; Laux Gerd; Pfeiffer Herbert; Naber Dieter; Schmidt Lutz G; Gaebel Wolfgang; Klosterkötter Joachim; Heuser Isabella; Maier Wolfgang; Lemke Matthias R; Rüther Eckart; Klingberg Stefan; Gastpar Markus; Möller Hans-Jürgen; Riedel Michael
Attitude towards adherence in patients with schizophrenia at discharge.
Giegling Ina; Olgiati Paolo; Hartmann Annette M; Calati Raffaella; Möller Hans-Jürgen; Rujescu Dan; Serretti Alessandro
Personality and attempted suicide. Analysis of anger, aggression and impulsivity.
Möller Hans-Jürgen
Is evidence sufficient for evidence-based medicine?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans-Jürgen Möller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schennach-Wolff Rebecca; Jäger Markus; Seemüller Florian; Obermeier Michael; Messer Thomas; Laux Gerd; Pfeiffer Herbert; Naber Dieter; Schmidt Lutz G; Gaebel Wolfgang; Klosterkötter Joachim; Heuser Isabella; Maier Wolfgang; Lemke Matthias R; Rüther Eckart; Klingberg Stefan; Gastpar Markus; Möller Hans-Jürgen; Riedel Michael
Attitude towards adherence in patients with schizophrenia at discharge.
Journal of psychiatric research 2009;43(16):1294-301.
2009: Giegling Ina; Olgiati Paolo; Hartmann Annette M; Calati Raffaella; Möller Hans-Jürgen; Rujescu Dan; Serretti Alessandro
Personality and attempted suicide. Analysis of anger, aggression and impulsivity.
Journal of psychiatric research 2009;43(16):1262-71.
2009: Möller Hans-Jürgen
Is evidence sufficient for evidence-based medicine?
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S167-72.
2009: Möller Hans-Jürgen
Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge.
Psychiatry and clinical neurosciences 2009;63(5):595-612.
2009: Karch Susanne; Leicht Gregor; Giegling Ina; Lutz Jürgen; Kunz Jörg; Buselmeier Moritz; Hey Patric; Spörl Alexander; Jäger Lorenz; Meindl Thomas; Pogarell Oliver; Möller Hans-Jürgen; Hegerl Ulrich; Rujescu Dan; Mulert Christoph
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
Journal of psychiatric research 2009;43(15):1185-94.
2009: Koutsouleris Nikolaos; Schmitt Gisela J E; Gaser Christian; Bottlender Ronald; Scheuerecker Johanna; McGuire Philip; Burgermeister Bernhard; Born Christine; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.
The British journal of psychiatry : the journal of mental science 2009;195(3):218-26.
2009: Schmitt Gisela Johanna Elisabeth; Meisenzahl Eva Maria; Frodl Thomas; La Fougère Christian; Hahn Klaus; Möller Hans-Jürgen; Dresel Stefan
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.
Psychiatry research 2009;173(3):183-9.
2009: Schennach-Wolff Rebecca; Jäger Markus; Seemüller Florian; Obermeier Michael; Messer Thomas; Laux Gerd; Pfeiffer Herbert; Naber Dieter; Schmidt Lutz G; Gaebel Wolfgang; Huff Wolfgang; Heuser Isabella; Maier Wolfgang; Lemke Matthias R; Rüther Eckart; Buchkremer Gerd; Gastpar Markus; Möller Hans-Jürgen; Riedel Michael
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
Schizophrenia research 2009;113(2-3):210-7.
2009: Karch Susanne; Mulert Christoph; Thalmeier Tobias; Lutz Jürgen; Leicht Gregor; Meindl Thomas; Möller Hans-Jürgen; Jäger Lorenz; Pogarell Oliver
The free choice whether or not to respond after stimulus presentation.
Human brain mapping 2009;30(9):2971-85.
2009: Wobrock Thomas; Gruber Oliver; Schneider-Axmann Thomas; Wölwer Wolfgang; Gaebel Wolfgang; Riesbeck Mathias; Maier Wolfgang; Klosterkötter Joachim; Schneider Frank; Buchkremer Gerd; Möller Hans-Jürgen; Schmitt Andrea; Bender Stefan; Schlösser Ralf; Falkai Peter
Internal capsule size associated with outcome in first-episode schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(5):278-83.
2009: Koutsouleris Nikolaos; Meisenzahl Eva M; Davatzikos Christos; Bottlender Ronald; Frodl Thomas; Scheuerecker Johanna; Schmitt Gisela; Zetzsche Thomas; Decker Petra; Reiser Maximilian; Möller Hans-Jürgen; Gaser Christian
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.
Archives of general psychiatry 2009;66(7):700-12.
2009: Teipel Stefan J; Pogarell Oliver; Meindl Thomas; Dietrich Olaf; Sydykova Djyldyz; Hunklinger Ulrike; Georgii Bea; Mulert Christoph; Reiser Maximilian F; Möller Hans-Jürgen; Hampel Harald
Regional networks underlying interhemispheric connectivity: an EEG and DTI study in healthy ageing and amnestic mild cognitive impairment.
Human brain mapping 2009;30(7):2098-119.
2009: Henkel Verena; Seemüller Florian; Obermeier Michael; Adli Mazda; Bauer Michael; Mundt Christoph; Brieger Peter; Laux Gerhard; Bender Wolfram; Heuser Isabella; Zeiler Joachim; Gaebel Wolfgang; Mayr Andreas; Möller Hans-Jürgen; Riedel Michael
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Journal of affective disorders 2009;115(3):439-49.
2009: Severus W E; Kleindienst N; Evoniuk G; Bowden C; Möller H J; Bohus M; Frangou S; Greil W; Calabrese J R
Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Journal of affective disorders 2009;115(3):466-70.
2009: Damm J; Eser D; Schüle C; Möller H-J; Rupprecht R; Baghai T C
[Core symptoms of depression. Effectiveness of antidepressant therapy]
Der Nervenarzt 2009;80(5):515-6, 518, 520 passim.
2009: Montgomery Stuart A; Möller Hans-Jürgen
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
International clinical psychopharmacology 2009;24(3):111-8.
2009: Bokde Arun L W; Karmann Michaela; Teipel Stefan J; Born Christine; Lieb Martin; Reiser Maximilian F; Möller Hans-Jürgen; Hampel Harald
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
Journal of clinical psychopharmacology 2009;29(2):147-56.
2009: Zill P; Büttner A; Eisenmenger W; Müller J; Möller H-J; Bondy B
Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain.
Neuroscience 2009;159(4):1274-82.
2009: Riedel M; Eich F X; Möller H J
A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(3):149-53.
2009: Giegling Ina; Chiesa Alberto; Calati Raffaella; Hartmann Annette M; Möller Hans-Jürgen; De Ronchi Diana; Rujescu Dan; Serretti Alessandro
Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects?
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009;150B(3):434-8.
2009: Möller H J
[Relativising the significance of the results of metaanalyses: comments on the metaanalysis by Kirsch et al. 2008 regarding the effectiveness of modern antidepressants]
MMW Fortschritte der Medizin 2009;151(13):80-3.
2009: Scheuerecker J; Ufer S; Käpernick M; Wiesmann M; Brückmann H; Kraft E; Seifert D; Koutsouleris N; Möller H J; Meisenzahl E M
Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI.
Journal of psychiatric research 2009;43(6):607-14.
2009: Seemüller Florian; Riedel Michael; Obermeier Michael; Bauer Michael; Adli Mazda; Mundt Christoph; Holsboer Florian; Brieger Peter; Laux Gerd; Bender Wolfram; Heuser Isabella; Zeiler Joachim; Gaebel Wolfgang; Jäger Markus; Henkel Verena; Möller Hans-Jürgen
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):181-9.
2009: Möller Hans-Jürgen
Do "real world" studies on antipsychotics tell us the real truth?
World psychiatry : official journal of the World Psychiatric Association (WPA) 2009;8(1):32.
2009: Baghai T C; Volz H P; Möller H J
[Antidepressive pharmacotherapy. In slight and severe disease, young and old]
Der Internist 2009;50(2):235-43.
2009: Möller T; Born C; Reiser M F; Möller H-J; Hampel H; Teipel S J
[Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex]
Der Nervenarzt 2009;80(1):54-61.
2009: Giegling Ina; Moreno-De-Luca Daniel; Calati Raffaella; Hartmann Annette M; Möller Hans-Jürgen; De Ronchi Diana; Rujescu Dan; Serretti Alessandro
Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits.
Neuropsychobiology 2009;59(1):23-7.
2008: Dittmann Sandra; Hennig-Fast Kristina; Gerber Sonja; Seemüller Florian; Riedel Michael; Emanuel Severus W; Langosch Jens; Engel Rolf R; Möller Hans-Jürgen; Grunze Heinz C
Cognitive functioning in euthymic bipolar I and bipolar II patients.
Bipolar disorders 2008;10(8):877-87.
2008: Brunnauer Alexander; Laux Gerd; David Irmgard; Fric Mirijam; Hermisson Igor; Möller Hans-Jürgen
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
The Journal of clinical psychiatry 2008;69(12):1880-6.
2008: Frodl T; Koutsouleris N; Bottlender R; Born C; Jäger M; Mörgenthaler M; Scheuerecker J; Zill P; Baghai T; Schüle C; Rupprecht R; Bondy B; Reiser M; Möller H-J; Meisenzahl E M
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression.
Molecular psychiatry 2008;13(12):1093-101.
2008: Möller H J
[25 years of progress in psychiatry: we are heading in the right direction]
MMW Fortschritte der Medizin 2008;150(48):160-1.
2008: Wölwer Wolfgang; Brinkmeyer Jürgen; Riesbeck Mathias; Freimüller Lena; Klimke Ansgar; Wagner Michael; Möller Hans-Jürgen; Klingberg Stefan; Gaebel Wolfgang;
Neuropsychological impairments predict the clinical course in schizophrenia.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 5():28-34.
2008: Möller Hans-Jürgen
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 5():7-17.
2008: Scherk Harald; Backens Martin; Zill Peter; Schneider-Axmann Thomas; Wobrock Thomas; Usher Juliana; Reith Wolfgang; Falkai Peter; Möller Hans-Jürgen; Bondy Brigitta; Gruber Oliver
SNAP-25 genotype influences NAA/Cho in left hippocampus.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(11):1513-8.
2008: Frodl T; Möller H-J; Meisenzahl E
Neuroimaging genetics: new perspectives in research on major depression?
Acta psychiatrica Scandinavica 2008;118(5):363-72.
2008: Möller Hans-Jürgen; Riedel Michael; Jäger Markus; Wickelmaier Florian; Maier Wolfgang; Kühn Kai-Uwe; Buchkremer Gerhard; Heuser Isabella; Klosterkötter Joachim; Gastpar Markus; Braus Dieter F; Schlösser Ralf; Schneider Frank; Ohmann Christian; Riesbeck Mathias; Gaebel Wolfgang
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(7):985-97.
2008: Frodl Thomas S; Koutsouleris Nikolaos; Bottlender Ronald; Born Christine; Jäger Markus; Scupin Isabel; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Depression-related variation in brain morphology over 3 years: effects of stress?
Archives of general psychiatry 2008;65(10):1156-65.
2008: Hennig-Fast Kristina; Meister Franziska; Frodl Thomas; Beraldi Anna; Padberg Frank; Engel Rolf R; Reiser Maximilian; Möller Hans-Jürgen; Meindl Thomas
A case of persistent retrograde amnesia following a dissociative fugue: neuropsychological and neurofunctional underpinnings of loss of autobiographical memory and self-awareness.
Neuropsychologia 2008;46(12):2993-3005.
2008: Frodl Thomas; Zill Peter; Baghai Thomas; Schüle Cornelius; Rupprecht Rainer; Zetzsche Thomas; Bondy Brigitta; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(7):1003-7.
2008: Musil Richard; Spellmann Ilja; Riedel Michael; Dehning Sandra; Douhet Anette; Maino Katja; Zill Peter; Müller Norbert; Möller Hans-Jürgen; Bondy Brigitta
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.
Journal of psychiatric research 2008;42(12):963-70.
2008: Frodl Thomas; Jäger Markus; Smajstrlova Ivana; Born Christine; Bottlender Ronald; Palladino Tanja; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study.
Journal of psychiatry & neuroscience : JPN 2008;33(5):423-30.
2008: Möller H-J
[Conflict of interest declarations in scientific publications]
Der Nervenarzt 2008;79(9):1001-5.
2008: Jäger M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt L G; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke M R; Rüther E; Buchkremer G; Gastpar M; Riedel M; Bottlender R; Strauss A; Möller H-J
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
Pharmacopsychiatry 2008;41(5):190-5.
2008: Meisenzahl E M; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller H-J
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Pharmacopsychiatry 2008;41(5):169-75.
2008: van den Oord Edwin J C G; Kuo Po-Hsiu; Hartmann Annette M; Webb B Todd; Möller Hans-Jürgen; Hettema John M; Giegling Ina; Bukszár József; Rujescu Dan
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
Archives of general psychiatry 2008;65(9):1062-71.
2008: Giegling I; Hartmann A M; Genius J; Benninghoff J; Möller H-J; Rujescu D
Systems biology and complex neurobehavioral traits.
Pharmacopsychiatry 2008;41 Suppl 1():S32-6.
2008: Meisenzahl E M; Koutsouleris N; Bottlender R; Scheuerecker J; Jäger M; Teipel S J; Holzinger S; Frodl T; Preuss U; Schmitt G; Burgermeister B; Reiser M; Born C; Möller H-J
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study.
Schizophrenia research 2008;104(1-3):44-60.
2008: Stefansson Hreinn; Rujescu Dan; Cichon Sven; Pietiläinen Olli P H; Ingason Andres; Steinberg Stacy; Fossdal Ragnheidur; Sigurdsson Engilbert; Sigmundsson Thordur; Buizer-Voskamp Jacobine E; Hansen Thomas; Jakobsen Klaus D; Muglia Pierandrea; Francks Clyde; Matthews Paul M; Gylfason Arnaldur; Halldorsson Bjarni V; Gudbjartsson Daniel; Thorgeirsson Thorgeir E; Sigurdsson Asgeir; Jonasdottir Adalbjorg; Jonasdottir Aslaug; Bjornsson Asgeir; Mattiasdottir Sigurborg; Blondal Thorarinn; Haraldsson Magnus; Magnusdottir Brynja B; Giegling Ina; Möller Hans-Jürgen; Hartmann Annette; Shianna Kevin V; Ge Dongliang; Need Anna C; Crombie Caroline; Fraser Gillian; Walker Nicholas; Lonnqvist Jouko; Suvisaari Jaana; Tuulio-Henriksson Annamarie; Paunio Tiina; Toulopoulou Timi; Bramon Elvira; Di Forti Marta; Murray Robin; Ruggeri Mirella; Vassos Evangelos; Tosato Sarah; Walshe Muriel; Li Tao; Vasilescu Catalina; Mühleisen Thomas W; Wang August G; Ullum Henrik; Djurovic Srdjan; Melle Ingrid; Olesen Jes; Kiemeney Lambertus A; Franke Barbara; Sabatti Chiara; Freimer Nelson B; Gulcher Jeffrey R; Thorsteinsdottir Unnur; Kong Augustine; Andreassen Ole A; Ophoff Roel A; Georgi Alexander; Rietschel Marcella; Werge Thomas; Petursson Hannes; Goldstein David B; Nöthen Markus M; Peltonen Leena; Collier David A; St Clair David; Stefansson Kari
Large recurrent microdeletions associated with schizophrenia.
Nature 2008;455(7210):232-6.
2008: Spellmann Ilja; Müller Norbert; Musil Richard; Zill Peter; Douhet Anette; Dehning Sandra; Cerovecki Anja; Bondy Brigitta; Möller Hans-Jürgen; Riedel Michael
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
European archives of psychiatry and clinical neuroscience 2008;258(6):335-44.
2008: Bokde Arun Lawrence Warren; Lopez-Bayo Patricia; Born Christine; Dong Wentian; Meindl Thomas; Leinsinger Gerda; Teipel Stefan Johannes; Faltraco Frank; Reiser Maximilian; Möller Hans-Jürgen; Hampel Harald
Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study.
Psychiatry research 2008;163(3):248-59.
2008: Möller Hans-Jürgen; Baldwin David S; Goodwin Guy; Kasper Siegfried; Okasha Ahmed; Stein Dan J; Tandon Rajiv; Versiani Marcio;
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 3():3-23.
2008: Möller Hans-Jürgen
Do effectiveness ("real world") studies on antipsychotics tell us the real truth?
European archives of psychiatry and clinical neuroscience 2008;258(5):257-70.
2008: Mulert Christoph; Seifert Christian; Leicht Gregor; Kirsch Valerie; Ertl Matthias; Karch Susanne; Moosmann Matthias; Lutz Jürgen; Möller Hans-Jürgen; Hegerl Ulrich; Pogarell Oliver; Jäger Lorenz
Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making.
NeuroImage 2008;42(1):158-68.
2008: Zetzsche Thomas; Preuss Ulrich W; Frodl Thomas; Leinsinger Gerda; Born Christine; Reiser Maximilian; Hegerl Ulrich; Möller Hans-Jürgen; Meisenzahl Eva M
White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia.
European archives of psychiatry and clinical neuroscience 2008;258(5):278-84.
2008: Giegling Ina; Rujescu Dan; Mandelli Laura; Schneider Barbara; Hartmann Annette M; Schnabel Axel; Maurer Konrad; De Ronchi Diana; Möller Hans-Jürgen; Serretti Alessandro
Estrogen receptor gene 1 variants are not associated with suicidal behavior.
Psychiatry research 2008;160(1):1-7.
2008: Meisenzahl E M; Koutsouleris N; Gaser C; Bottlender R; Schmitt G J E; McGuire P; Decker P; Burgermeister B; Born C; Reiser Maximilian; Möller H-J
Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study.
Schizophrenia research 2008;102(1-3):150-62.
2008: Need Anna C; Attix Deborah K; McEvoy Jill M; Cirulli Elizabeth T; Linney Kristen N; Wagoner Ana Patricia; Gumbs Curtis E; Giegling Ina; Möller Hans-Jürgen; Francks Clyde; Muglia Pierandrea; Roses Allen; Gibson Greg; Weale Mike E; Rujescu Dan; Goldstein David B
Failure to replicate effect of Kibra on human memory in two large cohorts of European origin.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(5):667-8.
2008: Karch Susanne; Jäger Lorenz; Karamatskos Evangelos; Graz Christian; Stammel Andreas; Flatz Wilhelm; Lutz Jürgen; Holtschmidt-Täschner Bettina; Genius Just; Leicht Gregor; Pogarell Oliver; Born Christine; Möller Hans-Jürgen; Hegerl Ulrich; Reiser Maximilian; Soyka Michael; Mulert Christoph
Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses.
Journal of psychiatric research 2008;42(9):734-45.
2008: Möller Hans-Jürgen
Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 2():48-73.
2008: deVries Marten W; Müller Norbert; Möller Hans-Jürgen; Saugstad Lettew F
Emil Kraepelin's legacy: systematic clinical observation and the categorical classification of psychiatric diseases.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 2():1-2.
2008: Dittmann Sandra; Seemüller Florian; Grunze Heinz C; Schwarz Markus J; Zach Johanna; Fast Kristina; Born Christoph; Dargel Sascha; Engel Rolf R; Bernhard Britta; Möller Hans-Jürgen; Riedel Michael; Severus W Emanuel
The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.
The Journal of clinical psychiatry 2008;69(6):899-906.
2008: Kawohl Wolfram; Giegling Ina; Mavrogiorgou Paraskevi; Pogarell Oliver; Mulert Christoph; Möller Hans-Jürgen; Hegerl Ulrich; Rujescu Dan; Juckel Georg
Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(4):477-83.
2008: Seemüller Florian; Riedel Michael; Wickelmaier Florian; Adli Mazda; Mundt Christoph; Marneros Andreas; Laux Gerhard; Bender Wolfram; Heuser Isabella; Zeiler Joachim; Gaebel Wolfgang; Jäger Markus; Möller Hans-Jürgen; Henkel Verena
Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity.
Journal of affective disorders 2008;108(3):271-8.
2008: Frodl Thomas; Jäger Markus; Born Christine; Ritter Sabine; Kraft Eduard; Zetzsche Thomas; Bottlender Ronald; Leinsinger Gerda; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva
Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course.
Psychiatry research 2008;163(1):76-83.
2008: Curtis V A; Katsafouros K; Möller H-J; Medori R; Sacchetti E
Long-acting risperidone improves negative symptoms in stable psychotic patients.
Journal of psychopharmacology (Oxford, England) 2008;22(3):254-61.
2008: Ruhrmann S; Paruch J; Bechdolf A; Pukrop R; Wagner M; Berning J; Schultze-Lutter F; Janssen B; Gaebel W; Möller H-J; Maier W; Klosterkötter J
Reduced subjective quality of life in persons at risk for psychosis.
Acta psychiatrica Scandinavica 2008;117(5):357-68.
2008: Scheuerecker J; Ufer S; Zipse M; Frodl T; Koutsouleris N; Zetzsche T; Wiesmann M; Albrecht J; Brückmann H; Schmitt G; Möller H-J; Meisenzahl E M
Cerebral changes and cognitive dysfunctions in medication-free schizophrenia - an fMRI study.
Journal of psychiatric research 2008;42(6):469-76.
2008: Müller Norbert; Schennach Rebecca; Riedel Michael; Möller Hans-Jürgen
Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Expert review of neurotherapeutics 2008;8(4):527-36.
2008: Zetzsche T; Preuss U W; Bondy B; Frodl T; Zill P; Schmitt G; Koutsouleris N; Rujescu D; Born C; Reiser M; Möller H-J; Meisenzahl E M
5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorder.
Genes, brain, and behavior 2008;7(3):306-13.
2008: Jäger Markus; Riedel Michael; Schmauss Max; Pfeiffer Herbert; Laux Gerd; Naber Dieter; Gaebel Wolfgang; Huff Wolfgang; Schmidt Lutz G; Heuser Isabella; Buchkremer Gerhard; Kühn Kai-Uwe; Rüther Eckart; Hoff Paul; Gastpar Markus; Bottlender Ronald; Strauss Anton; Möller Hans-Jürgen
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Psychiatry research 2008;158(3):297-305.
2008: Schmitt G J E; la Fougère C; Dresel S; Frodl T; Hahn K; Möller H-J; Meisenzahl E M
Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients.
Schizophrenia research 2008;101(1-3):133-41.
2008: Juckel Georg; Mergl R; Prässl A; Mavrogiorgou P; Witthaus H; Möller H J; Hegerl U
Kinematic analysis of facial behaviour in patients with schizophrenia under emotional stimulation by films with "Mr. Bean".
European archives of psychiatry and clinical neuroscience 2008;258(3):186-91.
2008: Giegling Ina; Moreno-De-Luca Daniel; Rujescu Dan; Schneider Barbara; Hartmann Annette M; Schnabel Axel; Maurer Konrad; Möller Hans-Jürgen; Serretti Alessandro
Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147(3):308-15.
2008: Broich K; Möller H J
Pharmacogenetics, pharmacogenomics and personalized psychiatry: are we there yet?
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 1():1-2.
2008: Möller Hans-Jürgen; Johnson Sunny; Mateva Temenuzhka; Brecher Martin; Svensson Ola; Miller Frank; Meulien Didier;
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
International clinical psychopharmacology 2008;23(2):95-105.
2008: Severus W E; Kleindienst N; Seemüller F; Frangou S; Möller H J; Greil W
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
Bipolar disorders 2008;10(2):231-7.
2008: Tonelli L H; Stiller J; Rujescu D; Giegling I; Schneider B; Maurer K; Schnabel A; Möller H-J; Chen H H; Postolache T T
Elevated cytokine expression in the orbitofrontal cortex of victims of suicide.
Acta psychiatrica Scandinavica 2008;117(3):198-206.
2008: Fritze Jürgen; Aldenhoff Josef; Bergmann Frank; Eckermann Gabriel; Maier Wolfgang; Möller Hans-Jürgen; Gaebel Wolfgang
[Priority for atypical antipsychotics--comments on the article by Dose M. Priority for Atypicals? Current studies clarify some aspects. Psychiat Prax 2007; 34:46-49]
Psychiatrische Praxis 2008;35(2):94-7; author reply 97-8.
2008: Thalmeier Andreas; Dickmann Martin; Giegling Ina; Schneider Barbara; M Hartmann Annette; Maurer Konrad; Schnabel Axel; Kauert Gerold; Möller Hans-Jürgen; Rujescu Dan
Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(2):217-28.
2008: Möller Hans-Jürgen
The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2008;7(1):35-6.
2008: Kasper S; Gastpar M; Müller W E; Volz H P; Dienel A; Kieser M; Möller H J
Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.
European archives of psychiatry and clinical neuroscience 2008;258(1):59-63.
2008: Koutsouleris Nikolaos; Gaser Christian; Jäger Markus; Bottlender Ronald; Frodl Thomas; Holzinger Silvia; Schmitt Gisela J E; Zetzsche Thomas; Burgermeister Bernhard; Scheuerecker Johanna; Born Christine; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study.
NeuroImage 2008;39(4):1600-12.
2008: Pogarell Oliver; Koch Walter; Schaaff Nadine; Pöpperl Gabriele; Mulert Christoph; Juckel Georg; Möller Hans-Jürgen; Hegerl Ulrich; Tatsch Klaus
[123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.
European archives of psychiatry and clinical neuroscience 2008;258(1):40-7.
2008: Papakostas George I; Nelson J Craig; Kasper Siegfried; Möller Hans-Jürgen
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(2):122-7.
2008: Möller H-J
[Acute psychosis: in an emergency always still haloperidol?]
Deutsche medizinische Wochenschrift (1946) 2008;133(3):96.
2008: Gaebel Wolfgang; Zäske Harald; Baumann Anja E; Klosterkötter Joachim; Maier Wolfgang; Decker Petra; Möller Hans-Jürgen
Evaluation of the German WPA "program against stigma and discrimination because of schizophrenia--Open the Doors": results from representative telephone surveys before and after three years of antistigma interventions.
Schizophrenia research 2008;98(1-3):184-93.
2008: Rujescu Dan; Giegling Ina; Mandelli Laura; Schneider Barbara; Hartmann Annette M; Schnabel Axel; Maurer Konrad; Möller Hans-Jürgen; Serretti Alessandro
NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(1):42-8.
2008: Baghai Thomas C; Eser Daniela; Möller Hans-Jürgen
Effects of different antidepressant treatments on the core of depression.
Dialogues in clinical neuroscience 2008;10(3):309-20.
2008: Möller Hans-Jürgen
Is there a need for a new psychiatric classification at the current state of knowledge?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(2):82-5.
2008: Baghai Thomas C; Möller Hans-Jürgen
Electroconvulsive therapy and its different indications.
Dialogues in clinical neuroscience 2008;10(1):105-17.
2008: Möller Hans-Jürgen
Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(2):102-14.
2008: Soyka Michael; Kranzler Henry R; Berglund Mats; Gorelick David; Hesselbrock Victor; Johnson Bankole A; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(1):6-23.
2007: Ruhrmann S; Bechdolf A; Kühn K-U; Wagner M; Schultze-Lutter F; Janssen B; Maurer K; Häfner H; Gaebel W; Möller H-J; Maier W; Klosterkötter J;
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
The British journal of psychiatry. Supplement 2007;51():s88-95.
2007: Pogarell Oliver; Koch Walter; Pöpperl Gabriele; Tatsch Klaus; Jakob Franziska; Mulert Christoph; Grossheinrich Nicola; Rupprecht Rainer; Möller Hans-Jürgen; Hegerl Ulrich; Padberg Frank
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.
Psychiatry research 2007;156(3):251-5.
2007: Francks C; Maegawa S; Laurén J; Abrahams B S; Velayos-Baeza A; Medland S E; Colella S; Groszer M; McAuley E Z; Caffrey T M; Timmusk T; Pruunsild P; Koppel I; Lind P A; Matsumoto-Itaba N; Nicod J; Xiong L; Joober R; Enard W; Krinsky B; Nanba E; Richardson A J; Riley B P; Martin N G; Strittmatter S M; Möller H-J; Rujescu D; St Clair D; Muglia P; Roos J L; Fisher S E; Wade-Martins R; Rouleau G A; Stein J F; Karayiorgou M; Geschwind D H; Ragoussis J; Kendler K S; Airaksinen M S; Oshimura M; DeLisi L E; Monaco A P
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.
Molecular psychiatry 2007;12(12):1129-39, 1057.
2007: Braun Isabella; Genius Just; Grunze Heinz; Bender Andreas; Möller Hans-Jürgen; Rujescu Dan
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
Schizophrenia research 2007;97(1-3):254-63.
2007: Gaebel Wolfgang; Riesbeck Mathias; Wölwer Wolfgang; Klimke Ansgar; Eickhoff Matthias; von Wilmsdorff Martina; Jockers-Scherübl Maria C; Kühn Kai-Uwe; Lemke Matthias; Bechdolf Andreas; Bender Stefan; Degner Detlef; Schlösser Ralf; Schmidt Lutz G; Schmitt Andrea; Jäger Markus; Buchkremer Gerd; Falkai Peter; Klingberg Stefan; Köpcke Wolfgang; Maier Wolfgang; Häfner Heinz; Ohmann Christian; Salize Hans J; Schneider Frank; Möller Hans-Jürgen;
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
The Journal of clinical psychiatry 2007;68(11):1763-74.
2007: Montgomery Stuart A; Baldwin David S; Blier Pierre; Fineberg Naomi A; Kasper Siegfried; Lader Malcolm; Lam Raymond W; Lépine Jean-Pierre; Möller Hans-Jürgen; Nutt David J; Rouillon Frederic; Schatzberg Alan F; Thase Michael E
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Zetzsche Thomas; Preuss Ulrich; Frodl Thomas; Watz Dorothee; Schmitt Gisela; Koutsouleris Nikolaos; Born Christine; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva Maria
In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature.
Schizophrenia research 2007;96(1-3):34-45.
2007: Eser Daniela; Baghai Thomas C; Möller Hans-Jürgen
Evidence of agomelatine's antidepressant efficacy: the key points.
International clinical psychopharmacology 2007;22 Suppl 2():S15-9.
2007: Teipel Stefan J; Born Christine; Ewers Michael; Bokde Arun L W; Reiser Maximilian F; Möller Hans-Jürgen; Hampel Harald
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
NeuroImage 2007;38(1):13-24.
2007: Riedel Michael; Müller Norbert; Spellmann Ilja; Engel Rolf R; Musil Richard; Valdevit Rosamaria; Dehning Sandra; Douhet Anette; Cerovecki Anja; Strassnig Martin; Möller Hans-Jürgen
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
European archives of psychiatry and clinical neuroscience 2007;257(7):402-12.
2007: Sydykova Djyldyz; Stahl Robert; Dietrich Olaf; Ewers Michael; Reiser Maximilian F; Schoenberg Stefan O; Möller Hans-Jürgen; Hampel Harald; Teipel Stefan J
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study.
Cerebral cortex (New York, N.Y. : 1991) 2007;17(10):2276-82.
2007: Maier W; Möller H-J
[Meta-analyses. A tool for maximizing therapy study evidence?]
Der Nervenarzt 2007;78(9):1028-36.
2007: Riedel Michael; Spellmann Ilja; Strassnig Martin; Douhet Anette; Dehning Sandra; Opgen-Rhein Markus; Valdevit Rosamaria; Engel Rolf R; Kleindienst Nikolaus; Müller Norbert; Möller Hans-Jürgen
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
European archives of psychiatry and clinical neuroscience 2007;257(6):360-70.
2007: Möller H-J; Maier W
[Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making]
Der Nervenarzt 2007;78(9):1014-27.
2007: Möller Hans-Jürgen
Clinical evaluation of negative symptoms in schizophrenia.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(6):380-6.
2007: Giegling Ina; Rujescu Dan; Mandelli Laura; Schneider Barbara; Hartmann Annette M; Schnabel Axel; Maurer Konrad; De Ronchi Diana; Möller Hans-Jürgen; Serretti Alessandro
Tachykinin receptor 1 variants associated with aggression in suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(6):757-61.
2007: Meisenzahl E M; Schmitt G J; Scheuerecker J; Möller H-J
The role of dopamine for the pathophysiology of schizophrenia.
International review of psychiatry (Abingdon, England) 2007;19(4):337-45.
2007: Koch Walter; Schaaff Nadine; Pöpperl Gabriele; Mulert Christoph; Juckel Georg; Reicherzer Markus; Ehmer-von Geiso Christoff; Möller Hans-Jürgen; Hegerl Ulrich; Tatsch Klaus; Pogarell Oliver
[I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.
Journal of psychiatry & neuroscience : JPN 2007;32(4):234-40.
2007: Teipel Stefan J; Bokde Arun L W; Born Christine; Meindl Thomas; Reiser Maximilian; Möller Hans-Jürgen; Hampel Harald
Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
Brain : a journal of neurology 2007;130(Pt 7):1745-58.
2007: Yatham Lakshmi N; Vieta Eduard; Young Allan H; Möller Hans-Jürgen; Paulsson Björn; Vågerö Mårten
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
International clinical psychopharmacology 2007;22(4):212-20.
2007: Baumann A; Zäske H; Decker P; Klosterkötter J; Maier W; Möller H J; Gaebel W
[Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004]
Der Nervenarzt 2007;78(7):787-8, 790-5.
2007: Jäger M; Riedel M; Möller H-J
[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy]
Der Nervenarzt 2007;78(7):745-6, 749-52.
2007: Möller H-J; Schnitker J
[Prospective study using a modified Montgomery-Asberg Depression Scale]
Der Nervenarzt 2007;78(6):685-90.
2007: Mulert Christoph; Leicht Gregor; Pogarell Oliver; Mergl Roland; Karch Susanne; Juckel Georg; Möller Hans-Jürgen; Hegerl Ulrich
Auditory cortex and anterior cingulate cortex sources of the early evoked gamma-band response: relationship to task difficulty and mental effort.
Neuropsychologia 2007;45(10):2294-306.
2007: Riedel Michael; Spellmann Ilja; Müller Norbert; Möller Hans-Jürgen
[Schizophrenic patients in the family practice]
MMW Fortschritte der Medizin 2007;149 Suppl 2():98-101.
2007: Gietl Anton; Giegling Ina; Hartmann Annette M; Schneider Barbara; Schnabel Axel; Maurer Konrad; Möller Hans-Jürgen; Rujescu Dan
ABCG1 gene variants in suicidal behavior and aggression-related traits.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):410-6.
2007: Riedel Michael; Müller Norbert; Strassnig Martin; Spellmann Ilja; Severus Emanuel; Möller Hans-Jürgen
Quetiapine in the treatment of schizophrenia and related disorders.
Neuropsychiatric disease and treatment 2007;3(2):219-35.
2007: Karch Susanne; Graz Christian; Jager Lorenz; Karamatskos Evangelos; Flatz Andreas Stammel Wilhelm; Lutz Jürgen; Holtschmidt-Taschner Bettina; Genius Just; Reiser Gregor Leicht Maximilian; Möller Hans-Jürgen; Hegerl Ulrich; Soyka Michael; Mulert Christoph
Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2007;38(2):89-95.
2007: Mulert Christoph; Juckel Georg; Brunnmeier Michael; Karch Susanne; Leicht Gregor; Mergl Roland; Möller Hans-Jürgen; Hegerl Ulrich; Pogarell Oliver
Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2007;38(2):78-81.
2007: Frodl Thomas; Schüle Cornelius; Schmitt Gisela; Born Christine; Baghai Thomas; Zill Peter; Bottlender Ronald; Rupprecht Rainer; Bondy Brigitta; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Archives of general psychiatry 2007;64(4):410-6.
2007: Serretti Alessandro; Mandelli Laura; Giegling Ina; Schneider Barbara; Hartmann Annette M; Schnabel Axel; Maurer Konrad; Möller Hans-Jürgen; Rujescu Dan
HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(3):291-9.
2007: Zwanzger Peter; Eser Daniela; Völkel Nikolas; Baghai Thomas C; Möller Hans-Jürgen; Rupprecht Rainer; Padberg Frank
Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(2):285-9.
2007: Möller H-J; Langer S; Schmauss M
Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
Pharmacopsychiatry 2007;40(2):53-7.
2007: Mulert Christoph; Juckel Georg; Brunnmeier Michael; Karch Susanne; Leicht Gregor; Mergl Roland; Möller Hans-Jürgen; Hegerl Ulrich; Pogarell Oliver
Prediction of treatment response in major depression: integration of concepts.
Journal of affective disorders 2007;98(3):215-25.
2007: Zetzsche Thomas; Preuss Ulrich W; Frodl Thomas; Schmitt Gisela; Seifert Doerthe; Münchhausen Elmar; Tabrizi Shahram; Leinsinger Gerda; Born Christine; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder.
Psychiatry research 2007;154(2):157-70.
2007: Teipel Stefan J; Stahl Robert; Dietrich Olaf; Schoenberg Stefan O; Perneczky Robert; Bokde Arun L W; Reiser Maximilian F; Möller Hans-Jürgen; Hampel Harald
Multivariate network analysis of fiber tract integrity in Alzheimer's disease.
NeuroImage 2007;34(3):985-95.
2007: Jäger Markus; Riedel Michael; Messer Thomas; Laux Gerd; Pfeiffer Herbert; Naber Dieter; Schmidt Lutz G; Gaebel Wolfgang; Huff Wolfgang; Heuser Isabella; Kühn Kai-Uwe; Lemke Matthias R; Rüther Eckart; Buchkremer Gerhard; Gastpar Markus; Bottlender Ronald; Strauss Anton; Möller Hans-Jürgen
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
European archives of psychiatry and clinical neuroscience 2007;257(1):47-53.
2007: Rujescu D; Meisenzahl E M; Krejcova S; Giegling I; Zetzsche T; Reiser M; Born C M; Möller H-J; Veske A; Gal A; Finckh U
Plexin B3 is genetically associated with verbal performance and white matter volume in human brain.
Molecular psychiatry 2007;12(2):190-4, 115.
2007: Riedel Michael; Spellmann Ilja; Schwarz Markus J; Strassnig Martin; Sikorski Christopher; Möller Hans-Jürgen; Müller Norbert
Decreased T cellular immune response in schizophrenic patients.
Journal of psychiatric research 2007;41(1-2):3-7.
2007: Zill Peter; Büttner Andreas; Eisenmenger Wolfgang; Möller Hans-Jürgen; Ackenheil Manfred; Bondy Brigitta
Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study.
Journal of psychiatric research 2007;41(1-2):168-73.
2007: Scheuerecker J; Frodl T; Koutsouleris N; Zetzsche T; Wiesmann M; Kleemann A M; Brückmann H; Schmitt G; Möller H-J; Meisenzahl E M
Cerebral differences in explicit and implicit emotional processing--an fMRI study.
Neuropsychobiology 2007;56(1):32-9.
2007: Teipel S J; Mitchell A J; Möller H J; Hampel H
Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods.
Journal of neural transmission. Supplementum 2007;(72):241-7.
2007: Herpertz Sabine C; Zanarini Mary; Schulz Charles S; Siever Larry; Lieb Klaus; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(4):212-44.
2007: Möller Hans-Jürgen
Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
Drugs 2007;67(11):1541-66.
2007: Möller Hans-Jürgen
Do effectiveness studies tell us the real truth?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(3):138-40.
2007: Bauer Michael; Bschor Tom; Pfennig Andrea; Whybrow Peter C; Angst Jules; Versiani Marcio; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(2):67-104.
2007: Rujescu Dan; Thalmeier Andreas; Möller Hans-Jürgen; Bronisch Thomas; Giegling Ina
Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system?
Archives of suicide research : official journal of the International Academy for Suicide Research 2007;11(1):17-40.
2007: Mergl Roland; Seidscheck Isabel; Allgaier Antje-Kathrin; Möller Hans-Jürgen; Hegerl Ulrich; Henkel Verena
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.
Depression and anxiety 2007;24(3):185-95.
2006: Möller H-J
[Psychiatric emergencies: who has responsibility for patient admission?]
Deutsche medizinische Wochenschrift (1946) 2006;131(50):2864.
2006: Meisenzahl E M; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller H J
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
European archives of psychiatry and clinical neuroscience 2006;256(8):522-31.
2006: Möller Hans-Jürgen
Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
European archives of psychiatry and clinical neuroscience 2006;256(8):476-96.
2006: Brunnauer Alexander; Laux Gerd; Geiger Elisabeth; Soyka Michael; Möller Hans-Jürgen
Antidepressants and driving ability: results from a clinical study.
The Journal of clinical psychiatry 2006;67(11):1776-81.
2006: Baghai T C; Binder E B; Schule C; Salyakina D; Eser D; Lucae S; Zwanzger P; Haberger C; Zill P; Ising M; Deiml T; Uhr M; Illig T; Wichmann H-E; Modell S; Nothdurfter C; Holsboer F; Müller-Myhsok B; Möller H-J; Rupprecht R; Bondy B
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism.
Molecular psychiatry 2006;11(11):1003-15.
2006: Giegling Ina; Hartmann Annette M; Möller Hans-Jürgen; Rujescu Dan
Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene.
Journal of affective disorders 2006;96(1-2):75-81.
2006: Pogarell Oliver; Juckel Georg; Mavrogiorgou Paraskevi; Mulert Christoph; Folkerts Malte; Hauke Walter; Zaudig Michael; Möller Hans-Jürgen; Hegerl Ulrich
Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2006;62(1):87-92.
2006: Frodl Thomas; Schaub Annette; Banac Sandra; Charypar Marketa; Jäger Markus; Kümmler Petra; Bottlender Ronald; Zetzsche Thomas; Born Christine; Leinsinger Gerda; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Reduced hippocampal volume correlates with executive dysfunctioning in major depression.
Journal of psychiatry & neuroscience : JPN 2006;31(5):316-23.
2006: Möller Hans-Jürgen
Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.
European archives of psychiatry and clinical neuroscience 2006;256(6):329-43.
2006: Teipel S; Ewers M; Dietrich O; Schoenberg S; Jessen F; Heun R; Freymann N; Möller H-J; Hampel H
[Reliability of multicenter magnetic resonance imaging. Results of a phantom test and in vivo measurements by the German Dementia Competence Network]
Der Nervenarzt 2006;77(9):1086-92, 1094-5.
2006: Zetzsche Thomas; Frodl Thomas; Preuss Ulrich W; Schmitt Gisela; Seifert Doerthe; Leinsinger Gerda; Born Christine; Reiser Maximilian; Möller Hans-Jürgen; Meisenzahl Eva M
Amygdala volume and depressive symptoms in patients with borderline personality disorder.
Biological psychiatry 2006;60(3):302-10.
2006: Teipel Stefan J; Drzezga Alexander; Bartenstein Peter; Möller Hans-Jürgen; Schwaiger Markus; Hampel Harald
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.
Psychopharmacology 2006;187(1):86-94.
2006: Müller N; Schwarz M J; Dehning S; Douhe A; Cerovecki A; Goldstein-Müller B; Spellmann I; Hetzel G; Maino K; Kleindienst N; Möller H-J; Arolt V; Riedel M
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Molecular psychiatry 2006;11(7):680-4.
2006: Teipel Stefan J; Pruessner Jens C; Faltraco Frank; Born Christine; Rocha-Unold Manoela; Evans Alan; Möller Hans-Jürgen; Hampel Harald
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
Journal of neurology 2006;253(6):794-800.
2006: Mulert Christoph; Juckel Georg; Giegling Ina; Pogarell Oliver; Leicht Gregor; Karch Susanne; Mavrogiorgou Paraskevi; Möller Hans-Jürgen; Hegerl Ulrich; Rujescu Dan
A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(6):1335-44.
2006: Pogarell Oliver; Koch Walter; Pöpperl Gabriele; Tatsch Klaus; Jakob Franziska; Zwanzger Peter; Mulert Christoph; Rupprecht Rainer; Möller Hans-Jürgen; Hegerl Ulrich; Padberg Frank
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
Journal of psychiatric research 2006;40(4):307-14.
2006: Möller Hans-Jürgen
Long-acting risperidone: focus on safety.
Clinical therapeutics 2006;28(5):633-51.
2006: Bokde A L W; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel S J; Möller H-J; Hampel H
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Brain : a journal of neurology 2006;129(Pt 5):1113-24.
2006: Teipel S J; Willoch F; Ishii K; Bürger K; Drzezga A; Engel R; Bartenstein P; Möller H-J; Schwaiger M; Hampel H
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
Neurobiology of aging 2006;27(5):681-90.
2006: Rujescu Dan; Bender Andreas; Keck Martin; Hartmann Annette M; Ohl Frauke; Raeder Hanna; Giegling Ina; Genius Just; McCarley Robert W; Möller Hans-Jürgen; Grunze Heinz
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
Biological psychiatry 2006;59(8):721-9.
2006: Bauer Michael; Möller Hans-Jürgen; Schneider Edith
Duloxetine: a new selective and dual-acting antidepressant.
Expert opinion on pharmacotherapy 2006;7(4):421-7.
2006: Schmitt G J E; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller H-J; Meisenzahl E M
Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
European archives of psychiatry and clinical neuroscience 2006;256(2):115-21.
2006: Forsthoff A; Hummel B; Möller H-J; Grunze H
[Suicidality and the Internet. Danger from new media]
Der Nervenarzt 2006;77(3):343-5.
2006: Schwarz Markus J; Krönig Holger; Riedel Michael; Dehning Sandra; Douhet Anette; Spellmann Ilja; Ackenheil Manfred; Möller Hans-Jürgen; Müller Norbert
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.
European archives of psychiatry and clinical neuroscience 2006;256(2):72-6.
2006: Bender W; Albus M; Möller H-J; Tretter F
Towards systemic theories in biological psychiatry.
Pharmacopsychiatry 2006;39 Suppl 1():S4-9.
2006: Glatz Daniela C; Rujescu Dan; Tang Yesheng; Berendt Frank J; Hartmann Annette M; Faltraco Frank; Rosenberg Carlyn; Hulette Christine; Jellinger Kurt; Hampel Harald; Riederer Peter; Möller Hans-J; Andreadis Athena; Henkel Kerstin; Stamm Stefan
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Journal of neurochemistry 2006;96(3):635-44.
2006: Van den Oord Edwin J C G; Rujescu Dan; Robles Jaime R; Giegling Ina; Birrell Claire; Bukszár József; Murrelle Lenn; Möller Hans-Jürgen; Middleton Lefkos; Muglia Pierandrea
Factor structure and external validity of the PANSS revisited.
Schizophrenia research 2006;82(2-3):213-23.
2006: Möller Hans-Jürgen; Grunze Heinz; Broich Karl
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
European archives of psychiatry and clinical neuroscience 2006;256(1):1-16.
2006: Fritz Jürgen; Aldenhoff J; Bermann F; Maier W; Möller H-J
[Antipsychotic agents in dementia]
Der Nervenarzt 2006;77(1):110-3.
2006: Sato Tetsuya; Bottlender Ronald; Sievers Marcus; Möller Hans-Jürgen
Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.
Journal of affective disorders 2006;90(1):1-5.
2006: Henkel Verena; Mergl Roland; Allgaier Antje-Kathrin; Kohnen Ralph; Möller Hans-Jürgen; Hegerl Ulrich
Treatment of depression with atypical features: a meta-analytic approach.
Psychiatry research 2006;141(1):89-101.
2006: Buerger Katharina; Otto Markus; Teipel Stefan J; Zinkowski Raymond; Blennow Kaj; DeBernardis John; Kerkman Daniel; Schröder Johannes; Schönknecht Peter; Cepek Lukas; McCulloch Cheryl; Möller Hans-Jürgen; Wiltfang Jens; Kretzschmar Hans; Hampel Harald
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Neurobiology of aging 2006;27(1):10-5.
2006: Rupprecht Rainer; Eser Daniela; Zwanzger Peter; Möller Hans-Jürgen
GABAA receptors as targets for novel anxiolytic drugs.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(4):231-7.
2006: Baghai Thomas C; Volz Hans-Peter; Möller Hans-Jürgen
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(4):198-222.
2006: Nothdurfter Caroline; Eser Daniela; Schüle Cornelius; Zwanzger Peter; Marcuse Alain; Noack Ines; Möller Hans-Jürgen; Rupprecht Rainer; Baghai Thomas C
The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(3):162-70.
2006: Baghai Thomas C; Marcuse Alain; Brosch Melanie; Schüle Cornelius; Eser Daniela; Nothdurfter Caroline; Steng Yvonne; Noack Ines; Pietschmann Katrin; Möller Hans-Jürgen; Rupprecht Rainer
The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(2):82-90.
2006: Möller Hans-Jürgen
Ethical aspects of publishing.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(2):66-9.
2006: Wölwer Wolfgang; Baumann Anja; Bechdolf Andreas; Buchkremer Gerhard; Häfner Heinz; Janssen Birgit; Klosterkötter Joachim; Maier Wolfgang; Möller Hans-Jürgen; Ruhrmann Stephan; Gaebel Wolfgang
The German Research Network on Schizophrenia--impact on the management of schizophrenia.
Dialogues in clinical neuroscience 2006;8(1):115-21.
2006: Falkai Peter; Wobrock Thomas; Lieberman Jeffrey; Glenthoj Birte; Gattaz Wagner F; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(1):5-40.
2006: Baghai Thomas C; Möller Hans-Jürgen; Rupprecht Rainer
Recent progress in pharmacological and non-pharmacological treatment options of major depression.
Current pharmaceutical design 2006;12(4):503-15.
2006: Möller H-J; Bottlender R
Severe mental illness in depression.
Acta psychiatrica Scandinavica. Supplementum 2006;(429):64-8.
2005: Möller Hans-Jürgen
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
European archives of psychiatry and clinical neuroscience 2005;255(6):371-2.
2005: Maier Wolfgang; Möller Hans-Jürgen
Metaanalyses - highest level of empirical evidence?
European archives of psychiatry and clinical neuroscience 2005;255(6):369-70.
2005: Riedel Michael; Müller Norbert; Strassnig Martin; Spellmann Ilja; Engel Rolf R; Musil Richard; Dehning Sandra; Douhet Anette; Schwarz Markus J; Möller Hans-Jürgen
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
European archives of psychiatry and clinical neuroscience 2005;255(6):432-7.
2005: Pogarell O; Ehrentraut S; Rüther T; Mulert C; Hegerl U; Möller H-J; Henkel V
Prolonged confusional state following electroconvulsive therapy--diagnostic clues from serial electroencephalography.
Pharmacopsychiatry 2005;38(6):316-20.
2005: Teipel Stefan J; Flatz Wilhelm H; Heinsen Helmut; Bokde Arun L W; Schoenberg Stefan O; Stöckel Stephanie; Dietrich Olaf; Reiser Maximilian F; Möller Hans-Jürgen; Hampel Harald
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Brain : a journal of neurology 2005;128(Pt 11):2626-44.
2005: Mulert Christoph; Jäger Lorenz; Propp Sebastian; Karch Susanne; Störmann Sylvère; Pogarell Oliver; Möller Hans-Jürgen; Juckel Georg; Hegerl Ulrich
Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI.
NeuroImage 2005;28(1):49-58.
2005: Soyka M; Koch W; Möller H J; Rüther T; Tatsch K
Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.
European archives of psychiatry and clinical neuroscience 2005;255(5):308-12.
2005: Schüle Cornelius; Baghai Thomas C; Alajbegovic Lejla; Schwarz Markus; Zwanzger Peter; Eser Daniela; Schaaf Ludwig; Möller Hans-Jürgen; Rupprecht Rainer
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
European archives of psychiatry and clinical neuroscience 2005;255(5):334-40.
2005: Schmitt G J E; Meisenzahl E M; Frodl T; La Fougère C; Hahn K; Möller H-J; Dresel S
The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Journal of psychopharmacology (Oxford, England) 2005;19(5):488-93.
2005: Jäger Markus; Bottlender Ronald; Strauss Anton; Möller Hans-Jürgen
Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.
Comprehensive psychiatry 2005;46(5):322-7.
2005: Möller H-J
Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot.
European psychiatry : the journal of the Association of European Psychiatrists 2005;20(5-6):379-85.
2005: Adam Dieter; Kasper S; Möller H-J; Singer E A;
Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees.
European archives of psychiatry and clinical neuroscience 2005;255(4):258-60.
2005: Riedel Michael; Schwarz M J; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller H J
Risperidone plasma levels, clinical response and side-effects.
European archives of psychiatry and clinical neuroscience 2005;255(4):261-8.
2005: Hampel Harald; Haslinger Andreas; Scheloske Michael; Padberg Frank; Fischer Petra; Unger Josef; Teipel Stefan Johannes; Neumann Michaela; Rosenberg Carlyn; Oshida Rusti; Hulette Christine; Pongratz Dieter; Ewers Michael; Kretzschmar H A; Möller Hans-Jürgen
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
European archives of psychiatry and clinical neuroscience 2005;255(4):269-78.
2005: Möller Hans-Jürgen
Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?
European archives of psychiatry and clinical neuroscience 2005;255(3):190-201.
2005: la Fougère Christian; Meisenzahl Eva; Schmitt Gisela; Stauss Jan; Frodl Thomas; Tatsch Klaus; Hahn Klaus; Möller Hans-Jürgen; Dresel Stefan
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1028-33.
2005: Padberg F; Möller H J; Bottlender R; Hampel H
[Modern therapy for dementia]
MMW Fortschritte der Medizin 2005;147 Spec No 2():71-4, 76-7.
2005: Bottlender R; Hampel H; Sievers M; Möller H J
[Diagnostics and therapy of depressive symptoms in schizophrenic patients]
MMW Fortschritte der Medizin 2005;147 Spec No 2():59-62.
2005: Möller Hans-Jürgen
Risperidone: a review.
Expert opinion on pharmacotherapy 2005;6(5):803-18.
2005: Hampel Harald; Bürger Katharina; Pruessner Jens C; Zinkowski Raymond; DeBernardis John; Kerkman Daniel; Leinsinger Gerda; Evans Alan C; Davies Peter; Möller Hans-Jürgen; Teipel Stefan J
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease.
Archives of neurology 2005;62(5):770-3.
2005: Möller Hans-Jürgen; Llorca Pierre-Michel; Sacchetti Emilio; Martin Stephen D; Medori Rossella; Parellada Eduard;
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
International clinical psychopharmacology 2005;20(3):121-30.
2005: Baghai T C; Marcuse A; Möller H-J; Rupprecht R
[Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995-2002]
Der Nervenarzt 2005;76(5):597-612.
2005: Brettschneider Sylvia; Morgenthaler Nils G; Teipel Stefan J; Fischer-Schulz Christina; Bürger Katharina; Dodel Richard; Du Yansheng; Möller Hans-Jürgen; Bergmann Andreas; Hampel Harald
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.
Biological psychiatry 2005;57(7):813-6.
2005: Möller Hans-Jürgen
Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.
European archives of psychiatry and clinical neuroscience 2005;255(2):83-93.
2005: Bokde Arun L W; Teipel Stefan J; Schwarz Robert; Leinsinger Gerda; Buerger Katharina; Moeller Tobias; Möller Hans-Juergen; Hampel Harald
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects.
Brain research. Brain research protocols 2005;14(3):135-45.
2005: Grünblatt E; Schlösser R; Fischer P; Fischer M O; Li J; Koutsilieri E; Wichart I; Sterba N; Rujescu D; Möller H J; Adamcyk W; Dittrich B; Müller F; Oberegger K; Gatterer G; Jellinger K J; Mostafaie N; Jungwirth S; Huber K; Tragl K H; Danielczyk W; Riederer P
Oxidative stress related markers in the "VITA" and the centenarian projects.
Neurobiology of aging 2005;26(4):429-38.
2005: Riedel M; Strassnig M; Müller N; Zwack P; Möller H-J
How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
European archives of psychiatry and clinical neuroscience 2005;255(2):143-8.
2005: Sievers M; Sato T; Möller H-J; Bottlender R
Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.
Pharmacopsychiatry 2005;38(2):104-5.
2005: Kleindienst N; Severus W E; Möller H-J; Greil W
Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?
European archives of psychiatry and clinical neuroscience 2005;255(1):72-4.
2005: Sato T; Bottlender R; Kleindienst N; Möller H-J
Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
Journal of affective disorders 2005;84(2-3):187-96.
2005: Henkel Verena; Mergl Roland; Möller Hans-Jürgen
Major depression is common in people over the age of 50, particularly in those at socioeconomic disadvantage, or with poor physical health and previous depressive symptoms.
Evidence-based mental health 2005;8(1):25.
2005: Rujescu D; Soyka M; Dahmen N; Preuss U; Hartmann A M; Giegling I; Koller G; Bondy B; Möller H-J; Szegedi A
GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):85-7.
2005: Preuss U W; Zetzsche T; Jäger M; Groll C; Frodl T; Bottlender R; Leinsinger G; Hegerl U; Hahn K; Möller H J; Meisenzahl E M
Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study.
Schizophrenia research 2005;73(1):91-101.
2005: Möller H J; Bauer M; Fritze J; Haen E; Laux G; Müller W E; Rüther E
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]
MMW Fortschritte der Medizin 2005;147(3):43-5.
2005: Sato Tetsuya; Bottlender Ronald; Sievers Marcus; Möller Hans-Jürgen
Evidence of depressive mixed states.
The American journal of psychiatry 2005;162(1):193-4; author reply 194.
2005: Pogarell O; Teipel S J; Juckel G; Gootjes L; Möller T; Bürger K; Leinsinger G; Möller H-J; Hegerl U; Hampel H
EEG coherence reflects regional corpus callosum area in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2005;76(1):109-11.
2005: Soyka Michael; Winter Catja; Kagerer Sabine; Brunnauer Manfred; Laux Gerd; Möller Hans-Jürgen
Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
Journal of psychiatric research 2005;39(1):101-8.
2005: Möller Hans-Jürgen
Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(4):247-63.
2005: Falkai Peter; Wobrock Thomas; Lieberman Jeffrey; Glenthoj Birte; Gattaz Wagner F; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(3):132-91.
2005: Möller Hans-Jürgen
Are placebo-controlled studies required in order to prove efficacy of antidepressants?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(3):130-1.
2005: Möller Hans-Jürgen
Problems associated with the classification and diagnosis of psychiatric disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(1):45-56.
2005: Hojaij Carlos; Möller Hans-Jürgen
A continuing success story.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(1):4-5.
2004: Henkel Verena; Mergl Roland; Coyne James C; Kohnen Ralf; Allgaier Antje-Kathrin; Rühl Elke; Möller Hans-Jürgen; Hegerl Ulrich
Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.
Journal of affective disorders 2004;83(2-3):237-42.
2004: Möller Hans-Jürgen; Curtis Vivienne A
The bipolar spectrum: diagnostic and pharmacologic considerations.
Expert review of neurotherapeutics 2004;4(6 Suppl 2):S3-8.
2004: Pogarell O; Juckel G; Mulert C; Amann B; Möller H-J; Hegerl U
EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
Pharmacopsychiatry 2004;37(6):304-5.
2004: Möller H J; Riedel M; Müller N; Fischer W; Kohnen R
Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Pharmacopsychiatry 2004;37(6):270-8.
2004: Möller H-J
Course and long-term treatment of schizophrenic psychoses.
Pharmacopsychiatry 2004;37 Suppl 2():126-35.
2004: Zill P; Baghai T C; Zwanzger P; Schüle C; Eser D; Rupprecht R; Möller H-J; Bondy B; Ackenheil M
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression.
Molecular psychiatry 2004;9(11):1030-6.
2004: Möller Hans-Jürgen
SSRIs: are the accusations justified?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(4):174-5.
2004: Rupprecht R; Möller H J
[Diagnosis and treatment of panic disorder]
MMW Fortschritte der Medizin 2004;146(42):45-6, 48.
2004: Zill Peter; Büttner Andreas; Eisenmenger Wolfgang; Möller Hans-Jürgen; Bondy Brigitta; Ackenheil Manfred
Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims.
Biological psychiatry 2004;56(8):581-6.
2004: Dodel R C; Du Y; Depboylu C; Hampel H; Frölich L; Haag A; Hemmeter U; Paulsen S; Teipel S J; Brettschneider S; Spottke A; Nölker C; Möller H J; Wei X; Farlow M; Sommer N; Oertel W H
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1472-4.
2004: Born Christine M; Meisenzahl Eva M; Frodl Thomas; Pfluger Thomas; Reiser Maximilian; Möller H J; Leinsinger Gerda L
The septum pellucidum and its variants. An MRI study.
European archives of psychiatry and clinical neuroscience 2004;254(5):295-302.
2004: Pogarell Oliver; Tatsch Klaus; Juckel Georg; Hamann Christine; Mulert Christoph; Pöpperl Gabriele; Folkerts Malte; Choukèr Martina; Riedel Michael; Zaudig Michael; Möller Hans-Jürgen; Hegerl Ulrich
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(10):1910-7.
2004: Rupprecht R; Soyka M; Grohmann R; Rüther E; Möller H-J
[Considerations in the combination of clozapine and benzodiazepines]
Der Nervenarzt 2004;75(9):857-60.
2004: Henkel Verena; Mergl Roland; Coyne James C; Kohnen Ralf; Möller Hans-Jürgen; Hegerl Ulrich
Screening for depression in primary care: will one or two items suffice?
European archives of psychiatry and clinical neuroscience 2004;254(4):215-23.
2004: Sato Tetsuya; Bottlender Ronald; Sievers Marcus; Schröter Andreas; Kleindienst Nikolaus; Möller Hans-Jürgen
Evaluating the inter-episode stability of depressive mixed states.
Journal of affective disorders 2004;81(2):103-13.
2004: Zill Peter; Baghai Thomas C; Engel Rolf; Zwanzger Peter; Schüle Cornelius; Eser Daniela; Behrens Stefanie; Rupprecht Rainer; Möller Hans-Jürgen; Ackenheil Manfred; Bondy Brigitta
The dysbindin gene in major depression: an association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;129B(1):55-8.
2004: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Möller Hans-Jürgen;
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):120-35.
2004: Möller Hans-Jürgen
Access to the world journal of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):118-9.
2004: Hampel H; Teipel S J; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller H-J; Blennow K; Buerger K
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Molecular psychiatry 2004;9(7):705-10.
2004: Mulert C; Pogarell O; Juckel G; Rujescu D; Giegling I; Rupp D; Mavrogiorgou P; Bussfeld P; Gallinat J; Möller H J; Hegerl U
The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators.
European archives of psychiatry and clinical neuroscience 2004;254(3):190-8.
2004: Bottlender R; Möller H J
[Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects.]
MMW Fortschritte der Medizin 2004;146 Spec No 2():19-23.
2004: Padberg F; Zwanzger P; Ella R; Rupprecht R; Möller H J
[Repetitive transcranial magnetic stimulation of the prefrontal cortex--the last resort in the treatment of depression?]
MMW Fortschritte der Medizin 2004;146 Spec No 2():16-7.
2004: Jäger Markus; Bottlender Ronald; Strauss Anton; Möller Hans-Jürgen
Classification of functional psychoses and its implication for prognosis: comparison between ICD-10 and DSM-IV.
Psychopathology 2004;37(3):110-7.
2004: Henkel Verena; Mergl Roland; Schäfer Martin; Rujescu Dan; Möller Hans-Jürgen; Hegerl Ulrich
Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
Pharmacopsychiatry 2004;37(3):110-8.
2004: Möller H-J
[Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities]
Der Nervenarzt 2004;75(5):499-515; quiz 516-7.
2004: Henkel Verena; Mergl Roland; Kohnen Ralf; Allgaier Antje-Kathrin; Möller Hans-Jürgen; Hegerl Ulrich
Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups.
General hospital psychiatry 2004;26(3):190-8.
2004: Mulert Christoph; Jäger Lorenz; Schmitt Robert; Bussfeld Patrick; Pogarell Oliver; Möller Hans-Jürgen; Juckel Georg; Hegerl Ulrich
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection.
NeuroImage 2004;22(1):83-94.
2004: Möller Hans-Jürgen
[Are placebo controlled studies on the proof of effectiveness of antidepressants necessary?]
Der Nervenarzt 2004;75(5):421-4.
2004: Brunnauer Alexander; Laux Gerd; Geiger Elisabeth; Möller Hans-Jürgen
The impact of antipsychotics on psychomotor performance with regards to car driving skills.
Journal of clinical psychopharmacology 2004;24(2):155-60.
2004: Gaebel Wolfgang; Möller Hans-Jürgen; Buchkremer Gerd; Ohmann Christian; Riesbeck Mathias; Wölwer Wolfgang; Von Wilmsdorff Martina; Bottlender Ronald; Klingberg Stefan
Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
European archives of psychiatry and clinical neuroscience 2004;254(2):129-40.
2004: Häfner Heinz; Maurer Kurt; Ruhrmann Stephan; Bechdolf Andreas; Klosterkötter Joachim; Wagner Michael; Maier Wolfgang; Bottlender Ronald; Möller Hans-Jürgen; Gaebel Wolfgang; Wölwer Wolfgang
Early detection and secondary prevention of psychosis: facts and visions.
European archives of psychiatry and clinical neuroscience 2004;254(2):117-28.
2004: Möller Hans-Jürgen
Non-neuroleptic approaches to treating negative symptoms in schizophrenia.
European archives of psychiatry and clinical neuroscience 2004;254(2):108-16.
2004: Hegerl Ulrich; Plattner Anita; Möller Hans-Jürgen
Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.
European archives of psychiatry and clinical neuroscience 2004;254(2):99-107.
2004: Frodl Thomas; Meisenzahl Eva M; Zetzsche Thomas; Höhne Tom; Banac Sandra; Schorr Constanze; Jäger Markus; Leinsinger Gerda; Bottlender Ronald; Reiser Maximilian; Möller Hans-Jürgen
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.
The Journal of clinical psychiatry 2004;65(4):492-9.
2004: Henkel Verena; Baghai Thomas C; Eser Daniela; Zill Peter; Mergl Roland; Zwanzger Peter; Schüle Cornelius; Bottlender Ronald; Jäger Markus; Rupprecht Rainer; Hegerl Ulrich; Möller Hans-Jürgen; Bondy Brigitta
The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;126B(1):82-7.
2004: Teipel Stefan J; Alexander Gene E; Schapiro Marc B; Möller Hans-Jürgen; Rapoport Stanley I; Hampel Harald
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Brain : a journal of neurology 2004;127(Pt 4):811-24.
2004: Sato Tetsuya; Bottlender Ronald; Schröter Andreas; Möller Hans-Jürgen
Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments.
Schizophrenia research 2004;67(2-3):175-83.
2004: Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig W-D; Wagner G; Müller-Oerlinghausen B; Möller H-J; Hippius H; Rüther E
Blood dyscrasias induced by psychotropic drugs.
Pharmacopsychiatry 2004;37 Suppl 1():S70-8.
2004: Stübner S; Rustenbeck E; Grohmann R; Wagner G; Engel R; Neundörfer G; Möller H-J; Hippius H; Rüther E
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
Pharmacopsychiatry 2004;37 Suppl 1():S54-64.
2004: Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller H-J; Hegerl U
Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Pharmacopsychiatry 2004;37(2):46-51.
2004: Rupprecht R; Baghai Th C; Möller H-J
[New developments in pharmacotherapy of depression]
Der Nervenarzt 2004;75(3):273-80.
2004: Frodl T; Meisenzahl E M; Möller H-J
[Value of diagnostic imaging in evaluation of electroconvulsive therapy]
Der Nervenarzt 2004;75(3):227-33.
2004: Hampel H; Mitchell A; Blennow K; Frank R A; Brettschneider S; Weller L; Möller H-J
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):247-72.
2004: Meisenzahl E M; Frodl T; Müller D; Schmitt G; Gallinat J; Zetzsche T; Marcuse A; Juckel G; Leinsinger G; Hahn K; Möller H J; Hegerl U
Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation.
Journal of psychiatric research 2004;38(2):153-62.
2004: Müller Norbert; Ulmschneider Markus; Scheppach Constanze; Schwarz Markus J; Ackenheil Manfred; Möller Hans-Jürgen; Gruber Rudolf; Riedel Michael
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
European archives of psychiatry and clinical neuroscience 2004;254(1):14-22.
2004: Jäger M; Bottlender R; Strauss A; Möller H-J
[The classification of functional psychoses: the impact of ICD-10 diagnoses (research diagnostic criteria) for the prediction of the long-term course]
Fortschritte der Neurologie-Psychiatrie 2004;72(2):70-8.
2004: Frodl Thomas; Meisenzahl Eva M; Zill Peter; Baghai Thomas; Rujescu Dan; Leinsinger Gerda; Bottlender Ronald; Schüle Cornelius; Zwanzger Peter; Engel Rolf R; Rupprecht Rainer; Bondy Brigitta; Reiser Maximilian; Möller Hans-Jürgen
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.
Archives of general psychiatry 2004;61(2):177-83.
2004: Bottlender Ronald; Sato Tetsuya; Kleindienst Nikolaus; Strauss Anton; Möller Hans Jürgen
Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder.
Journal of affective disorders 2004;78(2):149-52.
2004: Möller Hans-Jurgen
Novel antipsychotics in the long-term treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(1):9-19.
2004: Jäger M; Bottlender R; Strauss A; Möller H-J
Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders.
Acta psychiatrica Scandinavica 2004;109(1):30-7.
2004: Sato Tetsuya; Bottlender Ronald; Tanabe Akira; Möller Hans-Jürgen
Cincinnati criteria for mixed mania and suicidality in patients with acute mania.
Comprehensive psychiatry 2004;45(1):62-9.
2004: Gootjes L; Teipel S J; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller H-J; Hampel H
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Dementia and geriatric cognitive disorders 2004;18(2):180-8.
2004: Frölich Lutz; Fox Johannes; Padberg Frank; Maurer Konrad; Möller Hans-Jürgen; Hampel Harald
Targets of antidementive therapy: drugs with a specific pharmacological mechanism of action.
Current pharmaceutical design 2004;10(3):223-9.
2003: Wölwer Wolfgang; Buchkremer Gerhard; Häfner Heinz; Klosterkötter Joachim; Maier Wolfgang; Möller Hans-Jürgen; Gaebel Wolfgang
German research network on schizophrenia-bridging the gap between research and care.
European archives of psychiatry and clinical neuroscience 2003;253(6):321-9.
2003: Pogarell Oliver; Hamann Christine; Pöpperl Gabriele; Juckel Georg; Choukèr Martina; Zaudig Michael; Riedel Michael; Möller Hans-Jürgen; Hegerl Ulrich; Tatsch Klaus
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
Biological psychiatry 2003;54(12):1406-13.
2003: Möller H J
[49. Phobic disorder, panic or generalized anxiety? Basic principles in diagnosis and therapy]
MMW Fortschritte der Medizin 2003;145(47):I-VIII; quiz IX-X.
2003: Adli M; Rush A J; Möller H-J; Bauer M
Algorithms for optimizing the treatment of depression: making the right decision at the right time.
Pharmacopsychiatry 2003;36 Suppl 3():S222-9.
2003: Juckel Georg; Gallinat Jürgen; Riedel Michael; Sokullu Safet; Schulz Carl; Möller Hans-Jürgen; Müller Norbert; Hegerl Ulrich
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
Schizophrenia research 2003;64(2-3):115-24.
2003: Rujescu D; Hartmann A M; Gonnermann C; Möller H-J; Giegling I
M129V variation in the prion protein may influence cognitive performance.
Molecular psychiatry 2003;8(11):937-41.
2003: Möller Hans-Jürgen
Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(7):1101-11.
2003: Baghai T C; Möller H J
[How does it function? Electroconvulsive therapy]
MMW Fortschritte der Medizin 2003;145(40):59-60.
2003: Preuss U W; Rujescu D; Giegling I; Koller G; Bottlender M; Engel R R; Möller H J; Soyka M
[Factor structure and validity of a german version of the barratt impulsiveness scale]
Fortschritte der Neurologie-Psychiatrie 2003;71(10):527-34.
2003: Teipel Stefan J; Schapiro Mark B; Alexander Gene E; Krasuski Jack S; Horwitz Barry; Hoehne Christian; Möller Hans-Jürgen; Rapoport Stanley I; Hampel Harald
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
The American journal of psychiatry 2003;160(10):1870-8.
2003: Sato T; Bottlender R; Sievas M; Schröter A; Hecht S; Möller H-J
Long-term inter-episode stability of syndromes underlying mania.
Acta psychiatrica Scandinavica 2003;108(4):310-3.
2003: Bottlender R; Jäger M; Kunze I; Groll C; Borski I; Möller H-J
[Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives]
Der Nervenarzt 2003;74(9):762-6.
2003: Olsson Annika; Höglund Kina; Sjögren Magnus; Andreasen Niels; Minthon Lennart; Lannfelt Lars; Buerger Katharina; Möller Hans Jürgen; Hampel Harald; Davidsson Pia; Blennow Kaj
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Experimental neurology 2003;183(1):74-80.
2003: Bottlender Ronald; Sato Tetsuya; Groll Constanze; Jäger Markus; Kunze Ines; Möller Hans-Jürgen
Negative symptoms in depressed and schizophrenic patients: how do they differ?
The Journal of clinical psychiatry 2003;64(8):954-8.
2003: Rujescu Dan; Giegling Ina; Sato Tetsuya; Hartmann Annette M; Möller Hans Jürgen
Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis.
Biological psychiatry 2003;54(4):465-73.
2003: Jäger M D M; Hintermayr M; Bottlender R; Strauss A; Möller H-J
Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Focus on relapses and social adjustment.
European archives of psychiatry and clinical neuroscience 2003;253(4):209-15.
2003: Rujescu Dan; Giegling Ina; Gietl Anton; Gonnermann Claudia; Kirner Andre; Möller Hans-Jürgen; Dahmen Norbert
Association study of a SNP coding for a M129V substitution in the prion protein in schizophrenia.
Schizophrenia research 2003;62(3):289-91.
2003: Pukrop Ralf; Schlaak Volker; Möller-Leimkühler Anne Maria; Albus Margot; Czernik Adelheid; Klosterkötter Joachim; Möller Hans Jürgen
Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression.
Psychiatry research 2003;119(1-2):63-79.
2003: Rujescu Dan; Giegling Ina; Gietl Anton; Hartmann Annette M; Möller Hans-Jürgen
A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits.
Biological psychiatry 2003;54(1):34-9.
2003: Möller Hans-Jürgen; Demyttenaere Koen; Sacchetti Emilio; Rush A John; Montgomery Stuart A
Improving the chance of recovery from the short- and long-term consequences of depression.
International clinical psychopharmacology 2003;18(4):219-25.
2003: Zill Peter; Baghai Thomas C; Engel Rolf; Zwanzger Peter; Schüle Cornelius; Minov Christo; Behrens Stefanie; Bottlender Ronald; Jäger Markus; Rupprecht Rainer; Möller Hans-Jürgen; Ackenheil Manfred; Bondy Brigitta
Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;120B(1):85-9.
2003: Bottlender Ronald; Sato Tesuya; Jäger Markus; Wegener Ulrike; Wittmann Johannes; Strauss Anton; Möller Hans-Jürgen
The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia.
Schizophrenia research 2003;62(1-2):37-44.
2003: Gupta R K; Möller H-J
St. John's Wort. An option for the primary care treatment of depressive patients?
European archives of psychiatry and clinical neuroscience 2003;253(3):140-8.
2003: Fuchsberger T; Möller H J; Hampel H
[Current therapy of patients with dementia]
MMW Fortschritte der Medizin 2003;145 Suppl 2():49-52, 54.
2003: Jäger M; Bottlender R; Wegner U; Strauss A; Möller H J
[Diagnostic shifts of functional psychoses in the transition from ICD-9 to ICD-10]
Der Nervenarzt 2003;74(5):420-7.
2003: Jäger Markus; Bottlender Ronald; Strauss Anton; Möller Hans-Jürgen
On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses.
Psychopathology 2003;36(3):152-9.
2003: Zwanzger P; Eser D; Aicher S; Schüle C; Baghai T C; Padberg F; Ella R; Möller H-J; Rupprecht R
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(5):979-84.
2003: Sato T; Bottlender R; Schröter A; Möller H-J
Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum.
Acta psychiatrica Scandinavica 2003;107(4):268-74.
2003: Faltraco Frank; Bürger Katharina; Zill Peter; Teipel Stefan J; Möller Hans-Juergen; Hampel Harald; Bondy Brigitta; Ackenheil Manfred
Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.
Journal of the American Geriatrics Society 2003;51(4):578-9.
2003: Hegerl Ulrich; Mergl Roland; Henkel Verena; Gallinat Jürgen; Kotter Gerhard; Müller-Siecheneder Florian; Pogarell Oliver; Juckel Georg; Schröter Andreas; Bahra Ranbir; Emir Birol; Laux Gerd; Möller Hans-Jürgen
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
Journal of clinical psychopharmacology 2003;23(2):214-6.
2003: Bottlender Ronald; Sato Tetsuya; Jäger Markus; Kunze Ines; Groll Constanze; Borski Ingrid; Möller Hans Jürgen
Does considering duration of negative symptoms increase their specificity for schizophrenia?
Schizophrenia research 2003;60(2-3):321-2.
2003: Möller H J
[Antistigma and awareness program: saying no to the discrimination of the mentally ill]
MMW Fortschritte der Medizin 2003;145(12):33.
2003: Schüle Cornelius; Zwanzger Peter; Baghai Thomas; Mikhaiel Patrick; Thoma Heike; Möller Hans-Jürgen; Rupprecht Rainer; Padberg Frank
Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study.
Journal of psychiatric research 2003;37(2):145-53.
2003: Riedel M; Krönig H; Schwarz M J; Engel R R; Sikorski C; Kühn K-U; Behrens S; Möller H-J; Ackenheil M; Müller N
Investigation of the ICAM-1 G241A and A469G gene polymorphisms in schizophrenia.
Molecular psychiatry 2003;8(3):257-8.
2003: Zwanzger P; Jarry H; Eser D; Padberg F; Baghai T; Schule C; Ella R; Möller H-J; Rupprecht R
Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(3):313-6.
2003: Bondy Brigitta; Baghai Thomas C; Minov Christo; Schüle Cornelius; Schwarz Markus J; Zwanzger Peter; Rupprecht Rainer; Möller Hans J ürgen
Substance P serum levels are increased in major depression: preliminary results.
Biological psychiatry 2003;53(6):538-42.
2003: Bottlender Ronald; Sato Tetsuya; Möller Hans-Jürgen
Summer birth and deficit schizophrenia.
The American journal of psychiatry 2003;160(3):594-5; author reply 595-6.
2003: Schüle Cornelius; Baghai Thomas; Zwanzger Peter; Ella Robin; Eser Daniela; Padberg Frank; Möller Hans-Jürgen; Rupprecht Rainer
Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
Psychopharmacology 2003;166(3):271-5.
2003: Bagli Metin; Papassotiropoulos Andreas; Hampel Harald; Becker Karin; Jessen Frank; Bürger Katharina; Ptok U; Rao Marie Luise; Möller Hans-Jürgen; Maier Wolfgang; Heun Reinhard
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
European archives of psychiatry and clinical neuroscience 2003;253(1):44-8.
2003: Baldwin David; Broich Karl; Fritze Jürgen; Kasper Siegfried; Westenberg Herman; Möller Hans-Jürgen
Placebo-controlled studies in depression: necessary, ethical and feasible.
European archives of psychiatry and clinical neuroscience 2003;253(1):22-8.
2003: Frodl Thomas; Meisenzahl Eva Maria; Zetzsche Thomas; Born Christine; Jäger Markus; Groll Constanze; Bottlender Ronald; Leinsinger Gerda; Möller Hans-Jürgen
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects.
Biological psychiatry 2003;53(4):338-44.
2003: Buerger Katharina; Zinkowski Raymond; Teipel Stefan J; Arai Hiroyuki; DeBernardis John; Kerkman Daniel; McCulloch Cheryl; Padberg Frank; Faltraco Frank; Goernitz Alexander; Tapiola Tero; Rapoport Stanley I; Pirttilä Tuula; Möller Hans-Jürgen; Hampel Harald
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.
The American journal of psychiatry 2003;160(2):376-9.
2003: Tadic A; Rujescu D; Szegedi A; Giegling I; Singer P; Möller H-J; Dahmen N
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;117B(1):1-6.
2003: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Baldwin David; Licht Rasmus W; Vieta Eduard; Möller Hans-Jürgen;
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(1):5-13.
2003: Henkel Verena; Mergl Roland; Kohnen Ralf; Maier Wolfgang; Möller Hans-Jürgen; Hegerl Ulrich
Identifying depression in primary care: a comparison of different methods in a prospective cohort study.
BMJ (Clinical research ed.) 2003;326(7382):200-1.
2003: Rujescu Dan; Giegling Ina; Sato Tetsuya; Möller Hans-Jürgen
Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;116B(1):69-71.
2003: Teipel S J; Bayer W; Alexander G E; Bokde A L W; Zebuhr Y; Teichberg D; Müller-Spahn F; Schapiro M B; Möller H-J; Rapoport S I; Hampel H
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.
Neurobiology of aging 2003;24(1):85-94.
2003: Padberg Frank; Goldstein-Müller Barbara; Zwanzger Peter; Möller Hans-Jürgen
Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS.
Supplements to Clinical neurophysiology 2003;56():406-32.
2003: Zwanzger Peter; Eser Daniela; Padberg Frank; Baghai Thomas C; Schule Cornelius; Rötzer Florian; Ella Robin; Möller Hans-Jürgen; Rupprecht Rainer
Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
Depression and anxiety 2003;18(3):140-3.
2003: Möller H J
Suicide, suicidality and suicide prevention in affective disorders.
Acta psychiatrica Scandinavica. Supplementum 2003;(418):73-80.
2003: Möller Hans-Jürgen
Management of the negative symptoms of schizophrenia: new treatment options.
CNS drugs 2003;17(11):793-823.
2003: Kagerer Sabine; Winter Catja; Möller Hans-Jürgen; Soyka Michael
Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
Neuropsychobiology 2003;47(4):212-8.
2003: Möller Hans-Jürgen
Bipolar disorder and schizophrenia: distinct illnesses or a continuum?
The Journal of clinical psychiatry 2003;64 Suppl 6():23-7; discussion 28.
2003: Möller Hans-Jürgen; Nasrallah Henry A
Treatment of bipolar disorder.
The Journal of clinical psychiatry 2003;64 Suppl 6():9-17; discussion 28.
2003: Padberg Frank; Möller Hans-Jürgen
Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?
CNS drugs 2003;17(6):383-403.
2003: Schröter A; Mergl R; Bürger K; Hampel H; Möller H-J; Hegerl U
Kinematic analysis of handwriting movements in patients with Alzheimer's disease, mild cognitive impairment, depression and healthy subjects.
Dementia and geriatric cognitive disorders 2003;15(3):132-42.
2002: Steinmeyer E M; Klosterkötter J; Möller H J; Sass H; Herpertz S; Czernik A; Marcea J T; Matakas F; Mehne J; Bottländer H; Hesse W; Steinbring I; Pukrop R
[Personality and personality disorders II. The Specificity of the DAPP-model as a diagnostic system for personality disorders]
Fortschritte der Neurologie-Psychiatrie 2002;70(12):641-6.
2002: Steinmeyer E M; Klosterkötter J; Möller H J; Sass H; Herpertz S; Czernik A; Marcea J T; Matakas F; Mehne J; Bottländer H; Hesse W; Steinbring I; Pukrop R
[Personality and personality disorders I. Universality and sensitivity of dimensional personality models as diagnostic systems for personality disorders]
Fortschritte der Neurologie-Psychiatrie 2002;70(12):630-40.
2002: Preuss Ulrich W; Meisenzahl Eva M; Frodl Thomas; Zetzsche Thomas; Holder Jan; Leinsinger Gerda; Hegerl Ulrich; Hahn Klaus; Möller Hans-Jürgen
Handedness and corpus callosum morphology.
Psychiatry research 2002;116(1-2):33-42.
2002: Volz Hans-Peter; Murck Harald; Kasper Siegfried; Möller Hans-Jürgen
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Psychopharmacology 2002;164(3):294-300.
2002: Mavrogiorgou Paraskevi; Juckel Georg; Frodl Thomas; Gallinat Jürgen; Hauke Walter; Zaudig Michael; Dammann Gerhard; Möller Hans-Jürgen; Hegerl Ulrich
P300 subcomponents in obsessive-compulsive disorder.
Journal of psychiatric research 2002;36(6):399-406.
2002: Bandelow Borwin; Zohar Josef; Hollander Eric; Kasper Siegfried; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(4):171-99.
2002: Henkel V; Bussfeld P; Möller H-J; Hegerl U
Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?
European archives of psychiatry and clinical neuroscience 2002;252(5):240-9.
2002: Riedel Michael; Krönig Holger; Schwarz Markus J; Engel Rolf R; Kühn Kai-Uwe; Sikorski Christopher; Sokullu Safet; Ackenheil Manfred; Möller Hans-Jürgen; Müller Norbert
No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.
European archives of psychiatry and clinical neuroscience 2002;252(5):232-4.
2002: Bottlender Ronald; Sato Tetsuya; Jäger Markus; Groll Constanze; Strauss Anton; Möller Hans-Jürgen
The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients.
European archives of psychiatry and clinical neuroscience 2002;252(5):226-31.
2002: Möller H J
[Detecting and treating suicidal risk patients: a challenge for the general practitioner]
MMW Fortschritte der Medizin 2002;144(40):I-IX; quiz X-XII.
2002: Padberg Frank; Zwanzger Peter; Keck Martin E; Kathmann Norbert; Mikhaiel Patrick; Ella Robin; Rupprecht Philipp; Thoma Heike; Hampel Harald; Toschi Nicola; Möller Hans-Jürgen
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(4):638-45.
2002: Meisenzahl Eva M; Frodl Thomas; Zetzsche Thomas; Leinsinger Gerda; Maag Klaus; Hegerl Ulrich; Hahn Klaus; Möller Hans-Jürgen
Investigation of a possible diencephalic pathology in schizophrenia.
Psychiatry research 2002;115(3):127-35.
2002: Hirschfeld Robert M A; Montgomery Stuart A; Aguglia Eugenio; Amore Mario; Delgado Pedro L; Gastpar Markus; Hawley Christopher; Kasper Siegfried; Linden Michael; Massana Juan; Mendlewicz Julien; Möller Hans-Jürgen; Nemeroff Charles B; Saiz Jerónimo; Such Pedro; Torta Riccardo; Versiani Marcio
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
The Journal of clinical psychiatry 2002;63(9):826-37.
2002: Schmitt G J E; Meisenzahl E M; Dresel S; Tatsch K; Rossmüller B; Frodl T; Preuss U W; Hahn K; Möller H J
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
Journal of psychopharmacology (Oxford, England) 2002;16(3):200-6.
2002: Dodel Richard; Hampel Harald; Depboylu Candan; Lin Suizhen; Gao Feng; Schock Sabine; Jäckel Steffi; Wei Xing; Buerger Katharina; Höft Christine; Hemmer Bernhard; Möller Hans-Jürgen; Farlow Martin; Oertel Wolfgang H; Sommer Norbert; Du Yansheng
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
Annals of neurology 2002;52(2):253-6.
2002: Montgomery Stuart A; Bech Per; Blier Pierre; Möller Hans-Jürgen; Nierenberg Andrew A; Pinder Roger M; Quitkin Frederic M; Reimitz Paul-Egbert; Rosenbaum Jerrold F; Rush A John; Stassen H H; Thase Michael E
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Buerger Katharina; Zinkowski Raymond; Teipel Stefan J; Tapiola Tero; Arai Hiroyuki; Blennow Kaj; Andreasen Niels; Hofmann-Kiefer Klaus; DeBernardis John; Kerkman Daniel; McCulloch Cheryl; Kohnken Russell; Padberg Frank; Pirttilä Tuula; Schapiro Marc B; Rapoport Stanley I; Möller Hans-Jürgen; Davies Peter; Hampel Harald
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Archives of neurology 2002;59(8):1267-72.
2002: Peuskens J; Möller H J; Puech A
Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(4):305-10.
2002: Sato T; Bottlender R; Kleindienst N; Tanabe A; Möller H-J
The boundary between mixed and manic episodes in the ICD-10 classification.
Acta psychiatrica Scandinavica 2002;106(2):109-16.
2002: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Baldwin David; Licht Rasmus; Vieta Eduard; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(3):115-24.
2002: Bottlender R; Rudolf D; Jäger M; Strauss A; Möller H-J
Are bipolar I depressive patients less responsive to treatment with antidepressants than unipolar depressive patients? Results from a case control study.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17(4):200-5.
2002: Winkler D; Praschak-Rieder N; Willeit M; Lucht M J; Hilger E; Konstantinidis A; Stastny J; Thierry N; Pjrek E; Neumeister A; Möller H J; Kasper S
[Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics]
Der Nervenarzt 2002;73(7):637-43.
2002: Zill Peter; Baghai Thomas C; Zwanzger Peter; Schüle Cornelius; Minov Christo; Behrens Stefanie; Rupprecht Rainer; Möller Hans-Jürgen; Engel Rolf; Bondy Brigitta
Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression.
American journal of medical genetics 2002;114(5):530-2.
2002: Meisenzahl Eva M; Zetzsche Thomas; Preuss Ulrich; Frodl Thomas; Leinsinger Gerda; Möller Hans-Jürgen
Does the definition of borders of the planum temporale influence the results in schizophrenia?
The American journal of psychiatry 2002;159(7):1198-200.
2002: Frodl Thomas; Meisenzahl Eva M; Zetzsche Thomas; Born Christine; Groll Constanze; Jäger Markus; Leinsinger Gerda; Bottlender Ronald; Hahn Klaus; Möller Hans-Jürgen
Hippocampal changes in patients with a first episode of major depression.
The American journal of psychiatry 2002;159(7):1112-8.
2002: Möller Hans-Jürgen; Bottlender Ronald; Gross Anke; Hoff Paul; Wittmann Johannes; Wegner Ulrike; Strauss Anton
The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms.
Schizophrenia research 2002;56(1-2):87-94.
2002: Müller Norbert; Riedel Michael; Scheppach Constanze; Brandstätter Bernd; Sokullu Safet; Krampe Karin; Ulmschneider Markus; Engel Rolf R; Möller Hans-Jürgen; Schwarz Markus J
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
The American journal of psychiatry 2002;159(6):1029-34.
2002: Sato Tetsuya; Bottlender Ronald; Kleindienst Nikolaus; Möller Hans-Jürgen
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients.
The American journal of psychiatry 2002;159(6):968-74.
2002: Fuchsberger Th; Padberg F; Faltraco F; Möller H J; Hampel H
[Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer]
MMW Fortschritte der Medizin 2002;144(20):36-9.
2002: Hampel H; Teipel S J; Alexander G E; Pogarell O; Rapoport S I; Möller H-J
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):837-55.
2002: Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller H-J
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Pharmacopsychiatry 2002;35(3):119-21.
2002: Frodl Thomas; Meisenzahl Eva; Zetzsche Thomas; Bottlender Ronald; Born Christine; Groll Constanze; Jäger Markus; Leinsinger Gerda; Hahn Klaus; Möller Hans-Jürgen
Enlargement of the amygdala in patients with a first episode of major depression.
Biological psychiatry 2002;51(9):708-14.
2002: Padberg Frank; Schüle Cornelius; Zwanzger Peter; Baghai Thomas; Ella Robin; Mikhaiel Patrick; Hampel Harald; Möller Hans-Jürgen; Rupprecht Rainer
Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression.
Journal of psychiatric research 2002;36(3):131-5.
2002: Bauer Michael; Whybrow Peter C; Angst Jules; Versiani Marcio; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(2):69-86.
2002: Volz Hans-Peter; Möller Hans-Jürgen; Gerebtzoff Alexandre; Bischoff Serge
Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
European archives of psychiatry and clinical neuroscience 2002;252(2):76-80.
2002: Winkler D; Willeit M; Praschak-Rieder N; Lucht M J; Hilger E; Konstantinidis A; Stastny J; Thierry N; Pjrek E; Neumeister A; Möller H J; Kasper S
Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample.
European archives of psychiatry and clinical neuroscience 2002;252(2):54-62.
2002: Zill Peter; Engel Rolf; Baghai Thomas C; Juckel Georg; Frodl Thomas; Müller-Siecheneder Florian; Zwanzger Peter; Schüle Cornelius; Minov Christo; Behrens Stefanie; Rupprecht Rainer; Hegerl Ulrich; Möller Hans Jürgen; Bondy Brigitta
Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(4):489-93.
2002: Frodl Thomas; Hampel Harald; Juckel Georg; Bürger Katharina; Padberg Frank; Engel Rolf R; Möller Hans-Jürgen; Hegerl Ulrich
Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease.
Psychophysiology 2002;39(2):175-81.
2002: Ella Robin; Zwanzger Peter; Stampfer Robert; Preuss Ulrich W; Müller-Siecheneder Florian; Möller Hans-Jürgen; Padberg Frank
Switch to mania after slow rTMS of the right prefrontal cortex.
The Journal of clinical psychiatry 2002;63(3):249.
2002: Zill Peter; Engel Rolf; Baghai Thomas C; Zwanzger Peter; Schüle Cornelius; Minov Christo; Behrens Stefanie; Rupprecht Rainer; Möller Hans Jürgen; Bondy Brigitta
Analysis of polymorphisms in the olfactory G-protein Golf in major depression.
Psychiatric genetics 2002;12(1):17-22.
2002: Frodl Thomas; Meisenzahl Eva Maria; Müller Dirk; Holder Jan; Juckel Georg; Möller Hans Jürgen; Hegerl Ulrich
P300 subcomponents and clinical symptoms in schizophrenia.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2002;43(3):237-46.
2002: Teipel Stefan J; Bayer Wolfram; Alexander Gene E; Zebuhr York; Teichberg Diane; Kulic Luka; Schapiro Marc B; Möller Hans-Jürgen; Rapoport Stanley I; Hampel Harald
Progression of corpus callosum atrophy in Alzheimer disease.
Archives of neurology 2002;59(2):243-8.
2002: Zwanzger Peter; Minov Christo; Ella Robin; Schüle Cornelius; Baghai Thomas; Möller Hans-Jürgen; Rupprecht Rainer; Padberg Frank
Transcranial magnetic stimulation for panic.
The American journal of psychiatry 2002;159(2):315-6.
2002: Hampel Harald; Teipel Stefan J; Bayer Wolfram; Alexander Gene E; Schwarz Robert; Schapiro Mark B; Rapoport Stanley I; Möller Hans-Jürgen
Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease.
Journal of the neurological sciences 2002;194(1):15-9.
2002: Bauer Michael; Whybrow Peter C; Angst Jules; Versiani Marcio; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(1):5-43.
2002: Grunze H; Walden J; Dittmann S; Berger M; Bergmann A; Bräunig P; Dose M; Emrich H M; Gastpar M; Greil W; Krüger S; Möller H J; Uebelhack R
[Psychopharmacotherapy of bipolar affective diseases]
Der Nervenarzt 2002;73(1):4-17; quiz 18-9.
2002: Rujescu D; Meisenzahl E M; Giegling I; Kirner A; Leinsinger G; Hegerl U; Hahn K; Möller H-J
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments in healthy volunteers and schizophrenic patients.
NeuroImage 2002;15(1):200-6.
2002: Möller Hans-Jürgen
Anxiety associated with comorbid depression.
The Journal of clinical psychiatry 2002;63 Suppl 14():22-6.
2002: Rujescu D; Giegling I; Bondy B; Gietl A; Zill P; Möller H-J
Association of anger-related traits with SNPs in the TPH gene.
Molecular psychiatry 2002;7(9):1023-9.
2002: Tiemeier Henning; Pelzer Eva; Jönck Lothar; Möller Hans-Jürgen; Rao Marie Luise
Plasma catecholamines and selective slow wave sleep deprivation.
Neuropsychobiology 2002;45(2):81-6.
2001: Bottlender R; Jäger M; Groll C; Strauss A; Möller H J
Deficit states in schizophrenia and their association with the length of illness and gender.
European archives of psychiatry and clinical neuroscience 2001;251(6):272-8.
2001: Möller H J; Hartmann A; Kessler C; Rainer M; Brown T; Gamand S; Lehert P
Naftidrofuryl in the treatment of vascular dementia.
European archives of psychiatry and clinical neuroscience 2001;251(6):247-54.
2001: Möller H J; Bottlender R; Grunze H; Strauss A; Wittmann J
Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?
Journal of affective disorders 2001;67(1-3):141-6.
2001: Padberg F; Hampel H; Möller H J
[Alzheimer patients. To treat with anti-dementia drugs in spite of unanswered questions]
MMW Fortschritte der Medizin 2001;143(51-52):43-5.
2001: Möller H J
[Depression. A challenge for the general practitioner]
MMW Fortschritte der Medizin 2001;143 Suppl():34-46; quiz 47-8.
2001: Padberg F; Hampel H; Möller H J
[Alzheimer patients treated with anti-dementia drugs despite unanswered questions]
Fortschritte der Medizin. Originalien 2001;119(3-4):141-3.
2001: Zwanzger P; Baghai T C; Schuele C; Ströhle A; Padberg F; Kathmann N; Schwarz M; Möller H J; Rupprecht R
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(5):699-703.
2001: Möller H J
Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.
European archives of psychiatry and clinical neuroscience 2001;251(5):217-24.
2001: Zwanzger P; Baghai T; Boerner R J; Möller H J; Rupprecht R
Anxiolytic effects of vigabatrin in panic disorder.
Journal of clinical psychopharmacology 2001;21(5):539-40.
2001: Frodl T; Meisenzahl E M; Müller D; Leinsinger G; Juckel G; Hahn K; Möller H J; Hegerl U
The effect of the skull on event-related P300.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(9):1773-6.
2001: Zwanzger P; Baghai T C; Schüle C; Minov C; Padberg F; Möller H J; Rupprecht R
Tiagabine improves panic and agoraphobia in panic disorder patients.
The Journal of clinical psychiatry 2001;62(8):656-7.
2001: Zetzsche T; Meisenzahl E M; Preuss U W; Holder J J; Kathmann N; Leinsinger G; Hahn K; Hegerl U; Möller H J
In-vivo analysis of the human planum temporale (PT): does the definition of PT borders influence the results with regard to cerebral asymmetry and correlation with handedness?
Psychiatry research 2001;107(2):99-115.
2001: Meisenzahl E M; Rujescu D; Kirner A; Giegling I; Kathmann N; Leinsinger G; Maag K; Hegerl U; Hahn K; Möller H J
Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia.
The American journal of psychiatry 2001;158(8):1316-9.
2001: Möller H J
Past, present and future of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(3):156-8.
2001: Soyka M; Horak M; Morhart V; Möller H J
[The "qualified outpatient detoxification" model project]
Der Nervenarzt 2001;72(7):565-9.
2001: Henkel V; Wambach V; Möller H J; Hegerl U
[Diagnosis and therapy of depression. Key role for the family physician]
MMW Fortschritte der Medizin 2001;143 Suppl 2():19-25.
2001: Möller H J
[18. Depression: A challenge for the general practitioner]
MMW Fortschritte der Medizin 2001;143(18):I-XII; quiz XIII-XIV.
2001: Schäfer M; Rujescu D; Giegling I; Guntermann A; Erfurth A; Bondy B; Möller H J
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene.
The American journal of psychiatry 2001;158(5):802-4.
2001: Frodl T; Meisenzahl E M; Müller D; Greiner J; Juckel G; Leinsinger G; Hahn H; Möller H J; Hegerl U
Corpus callosum and P300 in schizophrenia.
Schizophrenia research 2001;49(1-2):107-19.
2001: Maurer I; Zierz S; Möller H
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.
Schizophrenia research 2001;48(1):125-36.
2001: Bottlender R; Rudolf D; Strauss A; Möller H J
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients.
Journal of affective disorders 2001;63(1-3):79-83.
2001: Möller H J; Volz H P; Reimann I W; Stoll K D
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Journal of clinical psychopharmacology 2001;21(1):59-65.
2001: Möller H J
Methodological issues in psychiatry: psychiatry as an empirical science.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(1):38-47.
2001: Möller H J
Empirical methodology as the main criterion of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(1):2p.
2001: Möller H J; Müller N; Hippius H
Molecular and clinical aspects of affective disorders--a hundred years after the Kraepelinian concept of manic-depressive psychosis.
Journal of affective disorders 2001;62(1-2):3-5.
2001: Möller H J
Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale.
European archives of psychiatry and clinical neuroscience 2001;251 Suppl 2():II13-20.
2001: Fritze J; Möller H J
Design of clinical trials of antidepressants: should a placebo control arm be included?
CNS drugs 2001;15(10):755-64.
2001: Henkel V; Mergl R; Juckel G; Rujescu D; Mavrogiorgou P; Giegling I; Möller H; Hegerl U
Assessment of handedness using a digitizing tablet: a new method.
Neuropsychologia 2001;39(11):1158-66.
2001: Padberg F; Juckel G; Prässl A; Zwanzger P; Mavrogiorgou P; Hegerl U; Hampel H; Möller H J
Prefrontal cortex modulation of mood and emotionally induced facial expressions: a transcranial magnetic stimulation study.
The Journal of neuropsychiatry and clinical neurosciences 2001;13(2):206-12.
2001: Zill P; Engel R; Hampel H; Behrens S; Bürger K; Padberg F; Stübner S; Möller H J; Ackenheil M; Bondy B
Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.
European archives of psychiatry and clinical neuroscience 2001;251(1):24-8.
2000: Möller H J; Glaser K; Leverkus F; Göbel C
Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression.
Pharmacopsychiatry 2000;33(6):206-12.
2000: Krupinski M; Fischer A; Grohmann R; Engel R R; Hollweg M; Möller H J
[Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]
Der Nervenarzt 2000;71(11):906-11.
2000: Zill P; Bürger K; Behrens S; Hampel H; Padberg F; Boetsch T; Möller H J; Ackenheil M; Bondy B
Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients.
Neuroscience letters 2000;294(2):69-72.
2000: Möller H J
State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2000;1(4):204-14.
2000: Akiskal H S; Bourgeois M L; Angst J; Post R; Möller H; Hirschfeld R
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.
Journal of affective disorders 2000;59 Suppl 1():S5-S30.
2000: Bürger K; Hampel H; Neumann M; Möller H J; Kretzschmar H
[Your help is needed! Autopsy brings new knowledge regarding Alzheimer dementia]
MMW Fortschritte der Medizin 2000;142(39):40-1.
2000: Tigges P; Mergl R; Frodl T; Meisenzahl E M; Gallinat J; Schröter A; Riedel M; Müller N; Möller H J; Hegerl U
Digitized analysis of abnormal hand-motor performance in schizophrenic patients.
Schizophrenia research 2000;45(1-2):133-43.
2000: Juckel G; Hegerl U; Mavrogiorgou P; Gallinat J; Mager T; Tigges P; Dresel S; Schröter A; Stotz G; Meller I; Greil W; Möller H J
Clinical and biological findings in a case with 48-hour bipolar ultrarapid cycling before and during valproate treatment.
The Journal of clinical psychiatry 2000;61(8):585-93.
2000: Stübner S; Padberg F; Grohmann R; Hampel H; Hollweg M; Hippius H; Möller H J; Rüther E
Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
The Journal of clinical psychiatry 2000;61(8):569-74.
2000: Bottlender R; Strauss A; Möller H J
Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients.
Schizophrenia research 2000;44(2):145-50.
2000: Soyka M; Bottlender R; Möller H J
Epidemiological evidence for a low abuse potential of zolpidem.
Pharmacopsychiatry 2000;33(4):138-41.
2000: Frölich L; Padberg F; Kratzsch T; Maurer K; Möller H J; Hampel H
[Therapy of Alzheimer dementia. Current status and prospects]
MMW Fortschritte der Medizin 2000;142(25):30-4.
2000: Djemai Zoghlache M; Bürger K; Schück S; Möller H J; Rapoport S I; Allain H; Hampel H
[Multiconceptual therapy in Alzheimer's disease]
Presse médicale (Paris, France : 1983) 2000;29(21):1197-201.
2000: Soyka M; Bondy B; Benda E; Preuss U; Hegerl U; Möller H
Platelet monoamine oxidase activity in alcoholics with and without a family history of alcoholism.
European addiction research 2000;6(2):57-63.
2000: Kohnken R; Buerger K; Zinkowski R; Miller C; Kerkman D; DeBernardis J; Shen J; Möller H J; Davies P; Hampel H
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.
Neuroscience letters 2000;287(3):187-90.
2000: Bottlender R; Möller H J
Monthly birth rates in residual and paranoid schizophrenic patients.
European psychiatry : the journal of the Association of European Psychiatrists 2000;15(3):227.
2000: Möller H J
Rating depressed patients: observer- vs self-assessment.
European psychiatry : the journal of the Association of European Psychiatrists 2000;15(3):160-72.
2000: Maurer I; Zierz S; Möller H J
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.
Neurobiology of aging 2000;21(3):455-62.
2000: Möller H J
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation]
Der Nervenarzt 2000;71(5):345-53.
2000: Möller H J
[Current assessment of new/atypical neuroleptic agents]
Der Nervenarzt 2000;71(5):329-44.
2000: Volz H P; Möller H J; Reimann I; Stoll K D
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(3):211-7.
2000: Meisenzahl E M; Frodl T; Zetzsche T; Leinsinger G; Heiss D; Maag K; Hegerl U; Hahn K; Möller H J
Adhesio interthalamica in male patients with schizophrenia.
The American journal of psychiatry 2000;157(5):823-5.
2000: Möller H J
Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2000;1(2):75-91.
2000: Hirschfeld R M; Montgomery S A; Keller M B; Kasper S; Schatzberg A F; Möller H J; Healy D; Baldwin D; Humble M; Versiani M; Montenegro R; Bourgeois M
Social functioning in depression: a review.
The Journal of clinical psychiatry 2000;61(4):268-75.
2000: Hampel H; Teipel S J; Alexander G E; Horwitz B; Pietrini P; Hippius H; Möller H J; Schapiro M B; Rapoport S I
Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;903():470-6.
2000: Kahle P J; Jakowec M; Teipel S J; Hampel H; Petzinger G M; Di Monte D A; Silverberg G D; Möller H J; Yesavage J A; Tinklenberg J R; Shooter E M; Murphy G M
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
Neurology 2000;54(7):1498-504.
2000: Bottlender R; Rudolf D; Strauss A; Möller H J
Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as "maniform syndromes" in bipolar I depression?
Pharmacopsychiatry 2000;33(2):75-7.
2000: Bottlender R; Strauss A; Möller H J
Prevalence and background factors of depression in first admitted schizophrenic patients.
Acta psychiatrica Scandinavica 2000;101(2):153-60.
2000: Hegerl U; Möller H J
[Pharmacotherapy of depression in the elderly]
Der Nervenarzt 2000;71(1):1-8.
2000: Möller H J
[Current pharmacologic therapy of depression]
Der Internist 2000;41(1):70-9.
2000: Möller H J; Bottlender R; Wegner U; Wittmann J; Strauss A
Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome.
Acta psychiatrica Scandinavica. Supplementum 2000;(407):54-7.
2000: Meisenzahl E M; Dresel S; Frodl T; Schmitt G J; Preuss U W; Rossmüller B; Tatsch K; Mager T; Hahn K; Möller H J
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
Journal of psychopharmacology (Oxford, England) 2000;14(4):364-70.
2000: Bottlender R; Jäger M; Strauss A; Möller H J
Suicidality in bipolar compared to unipolar depressed inpatients.
European archives of psychiatry and clinical neuroscience 2000;250(5):257-61.
2000: Tigges P; Juckel G; Schröter A; Möller H J; Hegerl U
Periodic motor impairments in a case of 48-hour bipolar ultrarapid cycling before and under treatment with valproate.
Neuropsychobiology 2000;42 Suppl 1():38-42.
2000: Rujescu D; Giegling I; Dahmen N; Szegedi A; Anghelescu I; Gietl A; Schäfer M; Müller-Siecheneder F; Bondy B; Möller H J
Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3.
Neuropsychobiology 2000;42 Suppl 1():22-5.
2000: Frodl T; Juckel G; Gallinat J; Bottlender R; Riedel M; Preuss U; Möller H J; Hegerl U
Dipole localization of P300 and normal aging.
Brain topography 2000;13(1):3-9.
2000: Pukrop R; Möller H J; Steinmeyer E M
Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life".
European archives of psychiatry and clinical neuroscience 2000;250(3):120-32.
2000: Möller H J; Grunze H
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
European archives of psychiatry and clinical neuroscience 2000;250(2):57-68.
2000: Möller H J
Amisulpride: a review of its efficacy in schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 2000;400():17-22.
2000: Möller H J
Are all antidepressants the same?
The Journal of clinical psychiatry 2000;61 Suppl 6():24-8.
1999: Bürger née Buch K; Padberg F; Nolde T; Teipel S J; Stübner S; Haslinger A; Schwarz M J; Sunderland T; Arai H; Rapoport S I; Möller H J; Hampel H
Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.
Neuroscience letters 1999;277(1):21-4.
1999: Möller H J
Effectiveness and safety of benzodiazepines.
Journal of clinical psychopharmacology 1999;19(6 Suppl 2):2S-11S.
1999: Peuskens J; Bech P; Möller H J; Bale R; Fleurot O; Rein W
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.
Psychiatry research 1999;88(2):107-17.
1999: Padberg F; Zwanzger P; Thoma H; Kathmann N; Haag C; Greenberg B D; Hampel H; Möller H J
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.
Psychiatry research 1999;88(3):163-71.
1999: Bottlender R; Buchberger A; Hoff P; Möller H J
[Decision-making and delusion. A study on decision-making in delusional, depressive and healthy subjects]
Der Nervenarzt 1999;70(11):987-92.
1999: Dittert S; Soyka M; Winter C; Möller H J
[Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol]
Fortschritte der Neurologie-Psychiatrie 1999;Suppl 2():S70-3.
1999: Möller H J
[Cognition in psychopathology]
Fortschritte der Neurologie-Psychiatrie 1999;Suppl 2():S43.
1999: Bottlender R; Möller H J
Negative symptoms due to sleep apnea syndrome in a patient with a delusional disorder.
European psychiatry : the journal of the Association of European Psychiatrists 1999;14(6):352.
1999: Padberg F; Feneberg W; Schmidt S; Schwarz M J; Körschenhausen D; Greenberg B D; Nolde T; Müller N; Trapmann H; König N; Möller H J; Hampel H
CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Journal of neuroimmunology 1999;99(2):218-23.
1999: Mergl R; Tigges P; Schröter A; Möller H J; Hegerl U
Digitized analysis of handwriting and drawing movements in healthy subjects: methods, results and perspectives.
Journal of neuroscience methods 1999;90(2):157-69.
1999: Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller H J; Tatsch K
In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
European journal of nuclear medicine 1999;26(8):862-8.
1999: Boerner R J; Möller H J
The importance of new antidepressants in the treatment of anxiety/depressive disorders.
Pharmacopsychiatry 1999;32(4):119-26.
1999: Burns A; Rossor M; Hecker J; Gauthier S; Petit H; Möller H J; Rogers S L; Friedhoff L T
The effects of donepezil in Alzheimer's disease - results from a multinational trial.
Dementia and geriatric cognitive disorders 1999;10(3):237-44.
1999: Möller H J
Reappraising neurotransmitter-based strategies.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9 Suppl 2():S53-9.
1999: Teipel S J; Hampel H; Pietrini P; Alexander G E; Horwitz B; Daley E; Möller H J; Schapiro M B; Rapoport S I
Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
Archives of neurology 1999;56(4):467-73.
1999: Wegner U; Meisenzahl E M; Möller H J; Kapfhammer H P
[Dysmorphophobia--symptom or diagnosis?]
Der Nervenarzt 1999;70(3):233-9.
1999: Massana J; Möller H J; Burrows G D; Montenegro R M
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder.
International clinical psychopharmacology 1999;14(2):73-80.
1999: Hampel H; Teipel S J; Padberg F; Haslinger A; Riemenschneider M; Schwarz M J; Kötter H U; Scheloske M; Buch K; Stübner S; Dukoff R; Lasser R; Müller N; Sunderland T; Rapoport S I; Möller H J
Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.
Brain research 1999;823(1-2):104-12.
1999: Hampel H; Padberg F; Buch K; Unger J; Stübner S; Möller H J
[Diagnosis and treatment of Alzheimer-type dementia]
Deutsche medizinische Wochenschrift (1946) 1999;124(5):124-9.
1999: Hampel H; Kötter H U; Padberg F; Körschenhausen D A; Möller H J
Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.
Alzheimer disease and associated disorders 1999;13(1):9-19.
1999: Pukrop R; Möller H J; Sass H; Sauer H; Klosterkötter J; Czernik A; Krausz M; Stieglitz R D; Lambert M; Matthies H; Schaub A; Woschnik M; Wulfinghoff F; Steinmeyer E M
[Quality of life. Construct validation and the development of a modular system]
Der Nervenarzt 1999;70(1):41-53.
1999: Stübner S; Schön T; Padberg F; Teipel S J; Schwarz M J; Haslinger A; Buch K; Dukoff R; Lasser R; Müller N; Sunderland T; Rapoport S I; Möller H J; Hampel H
Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130.
Neuroscience letters 1999;259(3):145-8.
1999: Frodl-Bauch T; Gallinat J; Meisenzahl E M; Möller H J; Hegerl U
P300 subcomponents reflect different aspects of psychopathology in schizophrenia.
Biological psychiatry 1999;45(1):116-26.
1999: Möller H J
Atypical neuroleptics: a new approach in the treatment of negative symptoms.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():99-107.
1999: Bottlender R; Wegner U; Wittmann J; Strauss A; Möller H J
Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():27-36.
1999: Meisenzahl E M; Frodl T; Greiner J; Leinsinger G; Maag K P; Heiss D; Hahn K; Hegerl U; Möller H J
Corpus callosum size in schizophrenia--a magnetic resonance imaging analysis.
European archives of psychiatry and clinical neuroscience 1999;249(6):305-12.
1999: Kasper S; Hale A; Azorin J M; Möller H J
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 2():II1-II14.
1999: Müller H; Möller H J; Stippel A; Fric M; Grünwald F; Laux G; Klemm E; Biersack H J
SPECT patterns in probable Alzheimer's disease.
European archives of psychiatry and clinical neuroscience 1999;249(4):190-6.
1999: Kleindienst N; Greil W; Rüger B; Möller H J
The prophylactic efficacy of lithium--transient or persistent?
European archives of psychiatry and clinical neuroscience 1999;249(3):144-9.
1998: Volz H P; Möller H J
[Opipramol in anxiety and somatoform disorders. Results of a controlled study]
Fortschritte der Neurologie-Psychiatrie 1998;66 Suppl 1():S21-4.
1998: Soyka M; Aichmüller C; Preuss U; Möller H J
Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics.
Pharmacopsychiatry 1998;31(6):232-5.
1998: Held T; Hawellek B; Dickopf-Kaschenbach K; Schneider-Axmann T; Schmidtke A; Möller H J
[Violent and non-violent methods of parasuicide: what determines the choice?]
Fortschritte der Neurologie-Psychiatrie 1998;66(11):505-11.
1998: Teipel S J; Hampel H; Alexander G E; Schapiro M B; Horwitz B; Teichberg D; Daley E; Hippius H; Möller H J; Rapoport S I
Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease.
Neurology 1998;51(5):1381-5.
1998: Möller H J; Gallinat J; Hegerl U; Arató M; Janka Z; Pflug B; Bauer H
Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression.
Pharmacopsychiatry 1998;31(5):170-7.
1998: Broich K; Grünwald F; Kasper S; Klemm E; Biersack H J; Möller H J
D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
Pharmacopsychiatry 1998;31(5):159-62.
1998: Ruhrmann S; Kasper S; Hawellek B; Martinez B; Höflich G; Nickelsen T; Möller H J
Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.
Psychological medicine 1998;28(4):923-33.
1998: Möller H J
[How are depressions treated today?]
Krankenpflege Journal 1998;36(6):224-6.
1998: Maurer I; Zierz S; Möller H J
Carnitine acyltransferases are not changed in Alzheimer disease.
Alzheimer disease and associated disorders 1998;12(2):71-6.
1998: Müller H; Möller H J
A regression analytical approach to estimate the onset of activity of antidepressants.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13(3):134-7.
1998: Möller H J; Gagiano C A; Addington D E; Von Knorring L; Torres-Plank J F; Gaussares C
Long-term treatment of chronic schizophrenia with risperidone: an open-label, multicenter study of 386 patients.
International clinical psychopharmacology 1998;13(3):99-106.
1998: Pietrini P; Teipel S J; Bartenstein P; Rapoport S I; Möller H J; Hampel H
PET and the effects of aging and neurodegeneration on brain function: basic principles.
Drug news & perspectives 1998;11(3):161-5.
1998: Ehrhardt T; Hampel H; Hegerl U; Möller H J
[Behavior therapy competence training--a specific intervention with beginning Alzheimer dementia]
Zeitschrift für Gerontologie und Geriatrie : Organ der Deutschen Gesellschaft für Gerontologie und Geriatrie 1998;31(2):112-9.
1998: Grunze H; Greene R W; Möller H J; Meyer T; Walden J
Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current.
Brain research 1998;791(1-2):330-4.
1998: Graeber M B; Kösel S; Grasbon-Frodl E; Möller H J; Mehraein P
Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.
Neurogenetics 1998;1(3):223-8.
1998: Möller H J
Novel antipsychotics and negative symptoms.
International clinical psychopharmacology 1998;13 Suppl 3():S43-7.
1998: Müller H; Möller H J
Methodological problems in the estimation of the onset of the antidepressant effect.
Journal of affective disorders 1998;48(1):15-23.
1998: Bottlender R; Dobmeier P; Möller H J
[The effect of selective serotonin-reuptake inhibitors in blood coagulation]
Fortschritte der Neurologie-Psychiatrie 1998;66(1):32-5.
1998: Hampel H; Sunderland T; Kötter H U; Schneider C; Teipel S J; Padberg F; Dukoff R; Levy J; Möller H J
Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.
Brain research 1998;780(2):356-9.
1998: Frodl T; Meisenzahl E M; Gallinat J; Hegerl U; Möller H J
Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia.
European archives of psychiatry and clinical neuroscience 1998;248(6):307-13.
1998: Bottlender R; Rudolf D; Strauss A; Möller H J
Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression.
European archives of psychiatry and clinical neuroscience 1998;248(6):296-300.
1998: Möller H J
Therapeutic strategies based on immunological hypotheses of Alzheimer's disease.
Journal of neural transmission. Supplementum 1998;54():175-86.
1998: Mielke R; Möller H J; Erkinjuntti T; Rosenkranz B; Rother M; Kittner B
Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials.
Alzheimer disease and associated disorders 1998;12 Suppl 2():S29-35.
1998: Danos P; Van Roos D; Kasper S; Brömel T; Broich K; Krappel C; Solymosi L; Möller H J
Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: a stereological CT study.
Neuropsychobiology 1998;38(2):80-3.
1998: Krupinski M; Fischer A; Grohmann R; Engel R; Hollweg M; Möller H J
Risk factors for suicides of inpatients with depressive psychoses.
European archives of psychiatry and clinical neuroscience 1998;248(3):141-7.
1998: Möller H J; Graeber M B
The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections.
European archives of psychiatry and clinical neuroscience 1998;248(3):111-22.
1998: Hegerl U; Bottlender R; Gallinat J; Kuss H J; Ackenheil M; Möller H J
The serotonin syndrome scale: first results on validity.
European archives of psychiatry and clinical neuroscience 1998;248(2):96-103.
1997: Müller N; Riedel M; Erfurth A; Möller H J
[Immunoglobulin therapy in Gilles de la Tourette syndrome]
Der Nervenarzt 1997;68(11):914-6.
1997: Sobanski T; Sieb J P; Laux G; Möller H J
[Acoustic hallucinations as a symptom of a REM sleep-associated parasomnia]
Psychiatrische Praxis 1997;24(6):302-3.
1997: Soyka M; Kirchmayer C; Kotter G; John C; Löhnert E; Möller H J
[New possibilities in therapy and rehabilitation of alcohol dependent patients. Catamnestic study of the efficacy of ambulatory withdrawal therapy exemplified by a model facility]
Fortschritte der Neurologie-Psychiatrie 1997;65(9):407-12.
1997: Maurer I; Möller H J
Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics.
Molecular and cellular biochemistry 1997;174(1-2):255-9.
1997: Marcusson J; Rother M; Kittner B; Rössner M; Smith R J; Babic T; Folnegovic-Smalc V; Möller H J; Labs K H
A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.
Dementia and geriatric cognitive disorders 1997;8(5):320-8.
1997: Möller H J; Boyer P; Fleurot O; Rein W
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.
Psychopharmacology 1997;132(4):396-401.
1997: Bottlender R; Erfurth A; Hoff P; Möller H J
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine]
Der Nervenarzt 1997;68(7):591-2.
1997: Volz H P; Gleiter C H; Möller H J
Brofaromine versus imipramine in in-patients with major depression--a controlled trial.
Journal of affective disorders 1997;44(2-3):91-9.
1997: Hampel H; Schoen D; Schwarz M J; Kötter H U; Schneider C; Sunderland T; Dukoff R; Levy J; Padberg F; Stübner S; Buch K; Müller N; Möller H J
Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.
Neuroscience letters 1997;228(3):143-6.
1997: Hampel H; Kötter H U; Möller H J
Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.
Alzheimer disease and associated disorders 1997;11(2):78-87.
1997: Graeber M B; Kösel S; Egensperger R; Banati R B; Müller U; Bise K; Hoff P; Möller H J; Fujisawa K; Mehraein P
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.
Neurogenetics 1997;1(1):73-80.
1997: Hampel H; Teipel S J; Kötter H U; Horwitz B; Pfluger T; Mager T; Möller H J; Müller-Spahn F
[Structural magnetic resonance tomography in diagnosis and research of Alzheimer type dementia]
Der Nervenarzt 1997;68(5):365-78.
1997: Rietschel M; Naber D; Fimmers R; Möller H J; Propping P; Nöthen M M
Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.
Neuroreport 1997;8(8):1999-2003.
1997: Bottlender R; Schütz C; Möller H J; Soyka M
Zolpidem dependence in a patient with former polysubstance abuse.
Pharmacopsychiatry 1997;30(3):108.
1997: Möller H J
[Pharmacotherapy of depressed patients. Increasing the therapeutic arsenal with a new generation of antidepressive drugs]
Fortschritte der Medizin 1997;115(11):30-4, 36.
1997: Haag C; Padberg F; Möller H J
[Transcranial magnetic stimulation. A diagnostic means from neurology as therapy in psychiatry?]
Der Nervenarzt 1997;68(3):274-8.
1997: Hollweg M; Kapfhammer H P; Krupinski M; Möller H J
[Psychopathological syndromes in treatment with gyrase inhibitors]
Der Nervenarzt 1997;68(1):38-47.
1997: Müller H; Möller H J
Methodological considerations and empirical data to the onset of efficacy of antidepressants and to the prediction of therapy outcome.
European psychiatry : the journal of the Association of European Psychiatrists 1997;12(4):177-82.
1997: Möller H J; Bäuml J; Ferrero F; Fuger J; Geretsegger C; Kasper S; Kissling W; Schubert H
Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland.
European archives of psychiatry and clinical neuroscience 1997;247(6):291-6.
1997: Hegerl U; Möller H J
Electroencephalography as a diagnostic instrument in Alzheimer's disease: reviews and perspectives.
International psychogeriatrics / IPA 1997;9 Suppl 1():237-46; discussion 247-52.
1997: Frodl-Bauch T; Kathmann N; Möller H J; Hegerl U
Dipole localization and test-retest reliability of frequency and duration mismatch negativity generator processes.
Brain topography 1997;10(1):3-8.
1997: Möller H J; Müller H
Statistical differentiation between direct and indirect effects of neuroleptics on negative symptoms.
European archives of psychiatry and clinical neuroscience 1997;247(1):1-5.
1996: Möller H J; Volz H P
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Drugs 1996;52(5):625-38.
1996: Klemm E; Danos P; Grünwald F; Kasper S; Möller H J; Biersack H J
Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomography.
Psychiatry research 1996;68(1):1-10.
1996: Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller H J; Propping P; Nöthen M M
Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(5):491-6.
1996: Rao M L; Pelzer E; Papassotiropoulos A; Tiemeier H; Jönck L; Möller H J
Selective slow-wave sleep deprivation influences blood serotonin profiles and serum melatonin concentrations in healthy subjects.
Biological psychiatry 1996;40(7):664-7.
1996: Rao M L; Ruhrmann S; Retey B; Liappis N; Fuger J; Kraemer M; Kasper S; Möller H J
Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
Pharmacopsychiatry 1996;29(5):180-6.
1996: Horn R; Ostertun B; Fric M; Solymosi L; Steudel A; Möller H J
Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment.
Dementia (Basel, Switzerland) 1996;7(4):182-6.
1996: Hegerl U; Juckel G; Möller H J
[Event related brain potentials as indicators of neurochemical dysfunctions in psychiatric patients]
Der Nervenarzt 1996;67(5):360-8.
1996: Volz H P; Gleiter C H; Möller H J
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]
Der Nervenarzt 1996;67(5):339-47.
1996: Rietschel M; Nöthen M M; Albus M; Maier W; Minges J; Bondy B; Körner J; Hemmer S; Fimmers R; Möller H J; Wildenauer D; Propping P
Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases.
Schizophrenia research 1996;20(1-2):181-6.
1996: Rao M L; Deister A; Laux G; Staberock U; Höflich G; Möller H J
Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Pharmacopsychiatry 1996;29(3):97-102.
1996: Adelhard K; Strauss A; Möller H J
[Correlation between symptoms and diagnosis in pharmacotherapeutic decision process]
Fortschritte der Neurologie-Psychiatrie 1996;64(4):123-31.
1996: Kraemer S; Hartl L; Böhmer M; Möller H J
[Psychophysiologic and psychologic correlates of the emotional family climate in schizophrenic patients and their family]
Der Nervenarzt 1996;67(3):219-28.
1996: Bagli M; Rao M L; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller H J
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
Arzneimittel-Forschung 1996;46(3):247-50.
1996: Möller H J; Müller H; Volz H P
How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.
Pharmacopsychiatry 1996;29(2):57-62.
1996: Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze A L; Möller H J; Biersack H J
[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
The American journal of psychiatry 1996;153(2):183-90.
1996: Volz H P; Gleiter C H; Waldmeier P C; Struck M; Möller H J
Brofaromine--a review of its pharmacological properties and therapeutic use.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):217-45.
1996: Möller H J
Review: treatment of schizophrenia. State of the art.
European archives of psychiatry and clinical neuroscience 1996;246(5):229-34.
1995: Bagli M; Höflich G; Rao M L; Langer M; Baumann P; Kolbinger M; Barlage U; Kasper S; Möller H J
Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.
International journal of clinical pharmacology and therapeutics 1995;33(12):646-52.
1995: Möller H J; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Pharmacopsychiatry 1995;28(6):249-52.
1995: Maurer I; Zierz S; Möller H J; Jerusalem F
Neuroleptic associated extrapyramidal symptoms.
The British journal of psychiatry : the journal of mental science 1995;167(4):551-2.
1995: Möller H J
The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptoms.
International clinical psychopharmacology 1995;10 Suppl 3():57-64.
1995: Volz H P; Müller H; Sturm Y; Preussler B; Möller H J
Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks.
Psychiatry research 1995;58(2):107-15.
1995: Nöthen M M; Rietschel M; Erdmann J; Oberländer H; Möller H J; Nober D; Propping P
Genetic variation of the 5-HT2A receptor and response to clozapine.
Lancet 1995;346(8979):908-9.
1995: Block W; Träber F; Kuhl C K; Fric M; Keller E; Lamerichs R; Rink H; Möller H J; Schild H H
[1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1995;163(3):230-7.
1995: Maurer I; Zierz S; Möller H J; Jerusalem F
Cytochrome c oxidase in Alzheimer's disease.
Neurology 1995;45(7):1423.
1995: Ahrens B; Grof P; Möller H J; Müller-Oerlinghausen B; Wolf T
Extended survival of patients on long-term lithium treatment.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1995;40(5):241-6.
1995: Höflich G; Kasper S; Burghof K W; Scholl H P; Möller H J
Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.
Biological psychiatry 1995;37(12):892-4.
1995: Kasper S; Möller H J; Montgomery S A; Zondag E
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
International clinical psychopharmacology 1995;9 Suppl 4():3-12.
1995: Möller H J; von Zerssen D
Self-rating procedures in the evaluation of antidepressants.
Psychopathology 1995;28(6):291-306.
1995: Möller H J
Dementia treatment: a German perspective on psychosocial aspects and therapeutic approaches.
International psychogeriatrics / IPA 1995;7(3):459-70.
1995: Möller H J
[Recent developments in antipsychotic medication]
Schweizer Archiv für Neurologie und Psychiatrie (Zurich, Switzerland : 1985) 1995;146(5):230-9.
1995: Volz H P; Müller H; Möller H J
Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?
Neuropsychobiology 1995;32(1):23-30.
1995: Möller H J
The negative component in schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 1995;388():11-4.
1995: Möller H J; Müller H; Borison R L; Schooler N R; Chouinard G
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
European archives of psychiatry and clinical neuroscience 1995;245(1):45-9.
1994: Volz H P; Stieglitz R D; Menges K; Möller H J
Somatoform disorders--diagnostic concept, controlled clinical trials, and methodological issues.
Pharmacopsychiatry 1994;27(6):231-7.
1994: Möller H J; Fuger J; Kasper S
Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studies.
Pharmacopsychiatry 1994;27(6):215-23.
1994: Martinez B; Kasper S; Ruhrmann S; Möller H J
Hypericum in the treatment of seasonal affective disorders.
Journal of geriatric psychiatry and neurology 1994;7 Suppl 1():S29-33.
1994: Möller H J
[Suicidal behavior. Clinical picture, diagnosis and therapy]
Der Internist 1994;35(9):849-56.
1994: Möller H J
[The effect of antidepressive agents on suicide in depressive patients]
Fortschritte der Neurologie-Psychiatrie 1994;62 Suppl 1():19-23.
1994: Möller H J; Maurer I; Saletu B
Placebo-controlled trial of the xanthine derivative propentofylline in dementia.
Pharmacopsychiatry 1994;27(4):159-65.
1994: Volz H P; Heimann H; Bellaire J; Laux G; Möller H J
Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
Pharmacopsychiatry 1994;27(4):152-8.
1994: Scholl H P; Kasper S; Danos P; Höflich G; Möller H J
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia]
Der Nervenarzt 1994;65(7):478-81.
1994: Möller H J
Non-response to antidepressants: risk factors and therapeutic possibilities.
International clinical psychopharmacology 1994;9 Suppl 2():17-23.
1994: Möller H J; van Praag H M; Aufdembrinke B; Bailey P; Barnes T R; Beck J; Bentsen H; Eich F X; Farrow L; Fleischhacker W W
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.
Psychopharmacology 1994;115(1-2):221-8.
1994: Volz H P; Möller H J
Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.
Pharmacopsychiatry 1994;27(3):93-100.
1994: Möller H J; Steinmeyer E M
Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(1):55-9.
1994: Danos P; Kasper S; Scholl H P; Kaiser J; Ruhrmann S; Höflich G; Möller H J
Clinical response to sleep deprivation and auditory-evoked potentials--preliminary results.
Pharmacopsychiatry 1994;27(2):70-1.
1994: Volz H P; Faltus F; Magyar I; Möller H J
Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
Journal of affective disorders 1994;30(3):209-17.
1994: Höflich G; Burghof K W; Kasper S; Möller H J
[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease]
Der Nervenarzt 1994;65(3):202-5.
1994: Kasper S; Ruhrmann S; Haase T; Möller H J
Evidence for a seasonal form of recurrent brief depression (RBD-seasonal).
European archives of psychiatry and clinical neuroscience 1994;244(4):205-10.
1994: Rao M L; Möller H J
Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. A review.
Neuropsychobiology 1994;30(4):160-72.
1994: Volz H P; Mackert A; Diefenbacher A; Friedrich A; Gaebel W; Müller H; Stock G; Möller H J
Orthostatic challenge during neuroleptic test dose: a possible predictor of short-term outcome.
Neuropsychobiology 1994;30(2-3):94-100.
1993: Möller H J; Volz H P
Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(4):501-10.
1993: Klemm E; Möller H J
[Aggressive episodes without amnesia. Differential diagnostic problems based on a case report]
Der Nervenarzt 1993;64(7):474-7.
1993: Grünwald F; Horn R; Rieker O; Klemm E; Menzel C; Möller H J; Biersack H J
[HMPAO-SPECT in Alzheimer-type dementia and major depression with memory disorders]
Nuklearmedizin. Nuclear medicine 1993;32(3):128-33.
1993: Möller H J; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf G A; Steinmeyer E M; Magyar I
Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Pharmacopsychiatry 1993;26(3):75-8.
1993: Kasper S; Dötsch M; Kick H; Vieira A; Möller H J
Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):13-21.
1993: Möller H J
Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):1-11.
1993: Möller H J; Krokenberger M; von Zerssen D
Prediction of short-term outcome of neurotic-depressive inpatients. Results of an empirical study of 134 inpatients.
European archives of psychiatry and clinical neuroscience 1993;242(5):301-9.
1992: Möller H J
Antidepressants--do they decrease or increase suicidality?
Pharmacopsychiatry 1992;25(6):249-53.
1992: Möller H J; Volz H P
Brofaromine in major depressed patients: a controlled clinical trial versus imipramine and open follow-up of up to one year.
Journal of affective disorders 1992;26(3):163-72.
1992: Möller H J
Attempted suicide: efficacy of different aftercare strategies.
International clinical psychopharmacology 1992;6 Suppl 6():58-69.
1992: Steinmeyer E M; Möller H J
Facet theoretic analysis of the Hamilton-D scale.
Journal of affective disorders 1992;25(1):53-61.
1992: Kasper S; Fuger J; Zinner H J; Bäuml J; Möller H J
Early clinical results with the neuroleptic roxindole (EMD 49,980) in the treatment of schizophrenia--an open study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1992;2(1):91-5.
1992: Kasper S; Ruhrmann S; Haase T; Möller H J
Recurrent brief depression and its relationship to seasonal affective disorder.
European archives of psychiatry and clinical neuroscience 1992;242(1):20-6.
1992: Kasper S; Fuger J; Möller H J
Comparative efficacy of antidepressants.
Drugs 1992;43 Suppl 2():11-22; discussion 22-3.
1991: Möller H J
[Therapy resistance to antidepressive drugs: risk factors and treatment possibilities]
Der Nervenarzt 1991;62(11):658-69.
1991: Möller H J; Pelzer E; Kissling W; Riehl T; Wernicke T
Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Pharmacopsychiatry 1991;24(6):185-9.
1991: Möller H J
[Drug treatment strategies in antidepressive drug therapy-resistant depression]
Klinische Wochenschrift 1991;69(9):413-5.
1991: Möller H J
Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
Pharmacopsychiatry 1991;24(3):71-5.
1991: Möller H J; Wendt G; Waldmeier P
Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings.
Pharmacopsychiatry 1991;24(2):50-4.
1991: Möller H J; Riehl T; Dietzfelbinger T; Wernicke T
A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
International clinical psychopharmacology 1991;6(3):179-92.
1990: Möller H J; Steinmeyer E M
Mood curves of neurotic-depressive patients undergoing treatment with antidepressants: time-series analyses of experience with HTAKA model.
Pharmacopsychiatry 1990;23(5):215-21.
1990: von Zerssen D; León C A; Möller H J; Wittchen H U; Pfister H; Sartorius N
Care strategies for schizophrenic patients in a transcultural comparison.
Comprehensive psychiatry 1990;31(5):398-408.
1990: Möller H J
[A real advance in therapy for clinical practice]
Fortschritte der Medizin. Supplement : die Kongressinformation für die Praxis 1990;103():17-9.
1990: Saletu B; Möller H J; Grünberger J; Deutsch H; Rössner M
Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Neuropsychobiology 1990;24(4):173-84.
1989: Möller H J
Efficacy of different strategies of aftercare for patients who have attempted suicide.
Journal of the Royal Society of Medicine 1989;82(11):643-7.
1989: Möller H J; Wendt G
[Brofaromine--a selective, reversible and short-acting MAO-A inhibitor]
Psychiatrische Praxis 1989;16 Suppl 1():32-6.
1989: Möller H J; Hohe-Schramm M; Cording-Tömmel C; Schmid-Bode W; Wittchen H U; Zaudig M; von Zerssen D
The classification of functional psychoses and its implications for prognosis.
The British journal of psychiatry : the journal of mental science 1989;154():467-72.
1989: Möller H J; Kissling W; Dietzfelbinger T; Stoll K D; Wendt G
Efficacy and tolerability of a new antipsychotic compound (savoxepine): results of a pilot-study.
Pharmacopsychiatry 1989;22(1):38-41.
1989: Möller H J; Blank R; Steinmeyer E M
Single-case evaluation of sleep-deprivation effects by means of nonparametric time-series analysis (according to the HTAKA model)
European archives of psychiatry and neurological sciences 1989;239(2):133-9.
1989: Möller H J; Kissling W; Riehl T; Bäuml J; Binz U; Wendt G
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(1-2):127-36.
1988: Möller H J; Haug G
Secondary and meta-analysis of the efficacy of non-tricyclic antidepressants.
Pharmacopsychiatry 1988;21(6):363-4.
1988: Möller H J; Meier K; Wernicke T
Empirical investigation on the risk of agranulocytosis/leucopenia under medication with antidepressants.
Pharmacopsychiatry 1988;21(6):304-5.
1988: Möller H J; Kissling W; Baumann P; Breyer-Pfaff U; Delini-Stula A; Holsboer F; Jungkunz G; Kuhs H; Laux G; Müller W E;
Non-response to antidepressants: risk factors and therapeutic possibilities.
Pharmacopsychiatry 1988;21(6):285-7.
1988: Riederer P; Laux G; Beckmann H; Saletu B; Waldmeier P; Fritze J; DaPrada M; Möller H J; Schmauss M; Przuntek H
The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives.
Pharmacopsychiatry 1988;21(6):283-4.
1988: Möller H J; Leitner M
Typology of mood assessment curves by means of cluster analysis of computerized mathematical descriptions of time-series mood data collected from depressive inpatients treated with antidepressants.
Pharmacopsychiatry 1988;21(4):192-6.
1988: Möller H J; Leitner M
A non-linear mathematical model for computerized analysis of mood curves: construction of the model and its application to the mood curves of depressive and schizophrenic inpatients.
Journal of affective disorders 1988;14(3):203-11.
1988: Möller H J; Schmid-Bode W; Cording-Tömmel C; Wittchen H U; Zaudig M; von Zerssen D
Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up.
Acta psychiatrica Scandinavica 1988;77(4):379-89.
1988: Möller H J; Hacker H
Study concerning the sample dependency and temporal variance of the factor structure in the Inpatient Multidimensional Psychiatric Scale.
Psychopathology 1988;21(6):281-90.
1987: Möller H J; Fischer G; von Zerssen D
Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.
European archives of psychiatry and neurological sciences 1987;236(6):349-57.
1987: Möller H J; Leitner M; Dietzfelbinger T
A linear mathematical model for computerized analyses of mood curves. An empirical investigation on mood courses in depressive and schizophrenic inpatients.
European archives of psychiatry and neurological sciences 1987;236(5):260-8.
1987: Möller H J; Leitner M
Optimizing a nonlinear mathematical approach for the computerized analysis of mood curves.
Psychopathology 1987;20(5-6):255-67.
1986: Möller H J; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
Pharmacopsychiatry 1986;19(5):362-4.
1986: Möller H J
[Neuroleptics and tranquilizers: indications and dangers]
Medizinische Klinik (Munich, Germany : 1983) 1986;81(11):385-8.
1986: Möller H J; Kissling W; Bottermann P
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
European archives of psychiatry and neurological sciences 1986;235(5):263-8.
1986: Möller H J; Schmid-Bode W; von Zerssen D
Prediction of long-term outcome in schizophrenia by prognostic scales.
Schizophrenia bulletin 1986;12(2):225-34.
1986: Möller H J; Kissling W
Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Clinical neuropharmacology 1986;9 Suppl 4():259-62.
1985: Möller H J; Scharl W; von Zerssen D
[Prediction of therapeutic success in acute neuroleptic treatment: results of an empirical study of 243 inpatient-treated schizophrenic patients]
Fortschritte der Neurologie-Psychiatrie 1985;53(10):370-83.
1985: Möller H J; von Zerssen D
[Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses]
Der Nervenarzt 1985;56(9):498-505.
1985: Kissling W; Möller H J; Walter K; Wittmann B; Krueger R; Trenk D
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Pharmacopsychiatry 1985;18(3):240-5.
1985: Bürk F; Kurz A; Möller H J
Suicide risk scales: do they help to predict suicidal behaviour?
European archives of psychiatry and neurological sciences 1985;235(3):153-7.
1984: Möller H J; Schmid-Bode W; von Zerssen D
[Development of new prognosis indices for patients with schizophrenic diseases and evaluation of their predictive validity]
Fortschritte der Neurologie-Psychiatrie 1984;52(12):421-7.
1984: Möller H J; Kissling W; Bottermann P
Serial application of clonidine tests during antidepressive treatment with chlorimipramine.
Pharmacopsychiatry 1984;17(6):184-7.
1984: Möller H J; Scharl W; von Zerssen D
[Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses]
Der Nervenarzt 1984;55(7):358-64.
1984: Möller H J; Kissling W; Herberger B; Kuss H J
[Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression]
Pharmacopsychiatry 1984;17(1):29-33.
1984: Möller H J
[Gangrene of the extremities following intravenous injection of neuroleptics]
Der Nervenarzt 1984;55(1):43-5.
1984: Möller H J; Griesshammer C; Hacker H
[Life change events preceding acute psychiatric diseases]
European archives of psychiatry and neurological sciences 1984;234(2):118-24.
1984: Möller H J; Scharl W; von Zerssen D
[The Strauss-Carpenter Scale: evaluation of its prognostic value for the 5-year outcome of schizophrenic patients]
European archives of psychiatry and neurological sciences 1984;234(2):112-7.
1983: Möller H J; Kissling W; von Zerssen D
[Prognostic value of the early response of psychiatric patients to neuroleptics for the subsequent course of treatment]
Pharmacopsychiatria 1983;16(2):46-9.
1983: Möller H J; von Zerssen D
[Psychopathometric procedures: II. Standardized assessment procedures]
Der Nervenarzt 1983;54(1):1-16.
1982: Möller H J; Kissling W; Lang C; Doerr P; Pirke K M; von Zerssen D
Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
The American journal of psychiatry 1982;139(12):1571-5.
1982: Möller H J; von Zerssen D
[Psychopathometric methods: I. General part]
Der Nervenarzt 1982;53(9):493-503.
1982: Möller H J; Werner-Eilert K; Wüschner-Stockheim M; von Zerssen D
[Relevant predictors of the 5 year outcome of patients with schizophrenic or similar paranoid psychoses (author's transl)]
Archiv für Psychiatrie und Nervenkrankheiten 1982;231(4):305-22.
1982: Möller H J; von Zerssen D; Werner-Eilert K; Wüschner-Stockheim M
Outcome in schizophrenic and similar paranoid psychoses.
Schizophrenia bulletin 1982;8(1):99-108.
1982: Möller H J; von Zerssen D
Depressive states occurring during the neuroleptic treatment of schizophrenia.
Schizophrenia bulletin 1982;8(1):109-17.
1981: Möller H J; von Zerssen D
[Depressive states in schizophrenic in-patients on admission and at discharge (author's transl)]
Der Nervenarzt 1981;52(9):525-30.
1981: Möller H J; von Zerssen D V
[Depressive states during the clinical treatment of 280 schizophrenic inpatients (author's transl)]
Pharmacopsychiatria 1981;14(5):172-9.
1981: Möller H J; von Zerssen D; Wüschner-Stockheim M; Werner-Eilert K
[The prognostic value of psychopathometric data about the psychopathological state of schizophrenic patients on admission and discharge (author's transl)]
Archiv für Psychiatrie und Nervenkrankheiten 1981;231(1):13-34.
1981: Emrich H M; von Zerssen D; Kissling W; Möller H J
On a possible role of GABA in mania. Therapeutic efficacy of sodium valproate.
Advances in biochemical psychopharmacology 1981;26():287-96.
1981: Möller H J; von Zerssen D; Werner-Eilert K; Wüschner-Stockheim M
[Psychopathometric examinations on patients with schizophrenia and related psychoses (author's transl)]
Archiv für Psychiatrie und Nervenkrankheiten 1981;230(4):275-92.
1980: Emrich H M; von Zerssen D; Kissling W; Möller H J; Windorfer A
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.
Archiv für Psychiatrie und Nervenkrankheiten 1980;229(1):1-16.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans-Jürgen Möller

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Procedures

Anatomy

Geographic Areas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans-Jürgen Möller (preview)

All Publications